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CHAPTER I 
 
INTRODUCTION TO WNT SIGNALING AND THE UBIQUITIN SYSTEM 
 
Introduction 
 The canonical Wnt signaling pathway is a highly conserved cell signaling 
pathway present in all metazoans that regulates many fundamental processes 
during development and maintains tissue homeostasis in adults. Misregulation of 
this pathway results in a variety of disease states in humans, including cancer.  
Wnt signaling is initiated upon Wnt ligand binding to its two co-receptors Frizzled 
(Fz) and low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6), which 
leads to stabilization and nuclear translocation of the main cytoplasmic effector β-
catenin.  Once in the nucleus, β-catenin converts the Wnt transcription factor 
TCF/Lef from a transcriptional repressor into an activator to initiate a Wnt-specific 
transcriptional program.  The Wnt pathway is heavily regulated by ubiquitylation, 
a post-translational modification in which the small protein ubiquitin is covalently 
attached to target proteins by a series of enzymes.  In this chapter, I begin with 
an introduction to cellular communication, Wnt signal transduction, and 
ubiquitylation to provide a background for understanding the studies I present in 
Chapters III-V.  In Chapter III, I describe a RNAi screen I performed to identify 
novel ubiquitin system components involved in regulating Wnt signaling and in 
Chapters IV and V I describe the identification of a novel E3 ubiquitin ligase and 
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de-ubiquitylase (DUB) involved in Wnt signal transduction, respectively.  I 
summarize these collective findings in Chapter VI.       
 
Signal Transduction:  How Cells Communicate 
The discovery of “animalcules” by Anton van Leeuwenhoek and of “cells” 
by Robert Hooke in the later half of the 17th century provided the foundation for 
the first unifying “cell theory” put forth nearly 200 years later by the botanist 
Matthias Jakob Schleiden and the zoologist Theodore Schwann (Mazzarello, 
1999).  Based on their work in which they discovered that both plants (Schleiden, 
1838) and animal tissues (Schwann, 1839) are composed of many individual 
cells, Schwann published a treatise in which he proposed that all living things are 
composed of cells and that cells are the fundamental units of life (Schwann, 
1839).  This was a pivotal moment in the history of biology as it indicated that 
organisms are “republics of living elementary units” (Mayr, 1982) and that by 
studying the “elementary units” (i.e. cells) one could thus learn how whole 
“republics” (i.e. whole plants and animals) form and function.  These findings 
quickly led to a reductionist approach to studying biology with a central focus on 
discovering how the minimal units of life (cells) function individually and in 
cooperation. 
Much has been learned about the function of cells since their initial 
discovery, but many fundamental questions still remain, including: What 
constitutes a cell?  How does it function?  How do cells respond to their 
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environment?  How do cells interact with other cells to form more complex life 
forms?  Initially, cells were thought to consist merely of a cell wall, cytoplasm, 
and a nucleus (Mazzarello, 1999).  We now know animal cells are separated 
from their external environment by a lipid bilayer (the plasma membrane) and 
contain water, multiple organelles, DNA, RNA, proteins, lipids, sugars, and ions 
that all interact in exquisitely complicated ways to ensure cells are able to survive 
and appropriately respond to their environment (Alberts, 2002).  While there is 
still much more to be learned about the make-up of a cell, there is even more to 
be learned about how cells are able to respond to an ever-changing environment 
and able to interact and communicate with multiple other cells to form multi-
cellular organisms. 
One of the major ways cells respond to their environment and 
communicate with other cells is through a process referred to as “signal 
transduction” (Gomperts, 2009).  Signal transduction is the process by which 
cells receive input from their surroundings (i.e. a “signal”) that can be in the form 
of light, temperature, chemicals, protein ligands, or physical forces that bind, or 
otherwise affect the function of, cell surface receptors, which then transmit the 
signal intracellularly (Gomperts, 2009). Cell surface receptors are typically 
proteins that span the plasma membrane (transmembrane proteins) and contain 
an extracellular domain that is able to interact with the extracellular environment 
and an intracellular domain that is able to transmit the signal intracellularly.  Once 
a signal is received by a cell surface receptor it initiates a cascade of intracellular 
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biochemical reactions that result in a variety of events depending on the signal, 
including changes in cellular metabolism, motility, gene transcription and even 
initiation of cell death (Gomperts, 2009). 
Single-celled organisms contain mostly two-component signaling systems 
to allow for appropriate environmental responses (Stock et al., 2000), whereas 
multi-cellular organisms (metazoa) require more complex signal transduction 
pathways to coordinate the development and maintenance of multiple cell types 
and tissues (Gerhart, 1999).  In fact, it is widely believed that the evolution of 
intercellular communication (cell-to-cell communication vs environment-to-cell 
communication) is what initially allowed the development of multi-cellular animals 
and plants (Alberts, 2002).  It is now clear that intercellular communication via 
signal transduction pathways is essential for coordinating the embryonic 
development of all animals (Gerhart, 1999; Pires-daSilva and Sommer, 2003).   
Despite the vast array of cell-types, tissue-types and morphologies found 
in the animal kingdom, it is estimated that only 17 signal transduction pathways 
exist to produce such diversity (Gerhart, 1999).  Even more striking is that only a 
few of the 17 total signal transduction pathways found in metazoa are repeatedly 
used during embryonic development.  This indicates that these few core, 
conserved pathways are utilized in many different ways to produce the 
abundance of phenotypes found throughout the animal kingdom (Gerhart, 1999; 
Pires-daSilva and Sommer, 2003).  These core pathways include:  Wnt, 
Hedghog (Hh), Notch, transforming growth factor β (TGF-β
 5 
kinase (RTK), Janus kinase (JAK)/signal transducer and activator of transcription 
(STAT), and nuclear hormone pathways.  A major remaining challenge for 
biologists is to define how these signaling pathways function, how they are 
employed during metazoan development to generate such diverse phenotypic 
outcomes, and how their misregulation leads to both aberrant development and 
to disease states in adults. 
 
Historical Perspective: Wnt Signaling 
 The Wnt signal transduction pathway is critical for the development of all 
multi-cellular organisms and is highly conserved from the most basal metazoan, 
Amphimedon queenslandica (a demosponge), to humans (Adamska et al., 2010; 
Gerhart, 1999; Richards and Degnan, 2009).  The Wnt pathway was discovered 
more than 30 years ago through a series of events that highlight its importance in 
both development and disease.   
 In 1976 Sharma and Chopra reported a Drosophila melanogaster 
mutant they named Wingless (Wg) because it lacked wings (Sharma and 
Chopra, 1976).  A few years later Eric Wieschaus and Christiane Nusslein-
Volhard performed their Nobel Prize-winning mutagenesis screen for segment 
polarity genes in Drosophila in which they showed Wg was required for proper 
segmentation of the early embryo (Nusslein-Volhard and Wieschaus, 1980).  
Together, these findings indicated an important role for Wg in Drosophila 
development.  In 1982, Roel Nusse and Harold Varmus reported that the Mouse 
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Mammary Tumor Virus integrates upstream of a novel proto-oncogene they 
called Integration 1 (Int1) (Nusse and Varmus, 1982).  Five years later it was 
discovered that Wg was the Drosophila ortholog of the mouse Int1 gene (Cabrera 
et al., 1987; Rijsewijk et al., 1987).  Subsequently the two names were combined 
into the mnemonic “Wnt;” a term which reflects its role in both fly development 
and carcinogenesis in mice (Nusse et al., 1991).  Around the same time, it was 
shown that injection of Int1 mRNA into Xenopus laevis embryos could induce a 
second body axis, demonstrating an important role for Int-1 in frog development 
in addition to its functions in flies and mice (McMahon and Moon).  Together, 
these findings indicated that the Wnt family of proteins are highly conserved 
across phyla and play important roles in both embryonic development and 
cancer.   
After Nusslein-Volhard and Wieschaus published their initial pioneering 
Drosophila mutagenesis screen for segment polarity regulators in which they 
identified Wg in 1980 (Nusslein-Volhard and Wieschaus, 1980), numerous 
papers followed that reported more Drosophila mutants with early embryonic 
patterning defects.  Many of these mutants turned out to be components of the 
Wnt signaling pathway including Armadillo (the Drosophila ortholog of β-catenin) 
(Riggleman et al., 1990; Wieschaus and Riggleman, 1987), Dishevelled (Dsh) 
(Perrimon and Mahowald, 1987), Shaggy (the Drosophila ortholog of glycogen 
synthase kinase 3 (GSK3)) (Siegfried et al., 1992), and Frizzled (Fz) (Bhanot et 
al., 1996).  These will be discussed further below.   
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In addition to the extensive work on the role of Wg in Drosophila 
development, much work was also performed in Xenopus embryos to further 
confirm a critical developmental role for Wnt signaling.  The initial finding that 
injection of Int1 mRNA into the ventral blastomeres of Xenopus embryos was 
sufficient to induce a second body axis (McMahon and Moon, 1989) was a 
monumental discovery as it finally provided a molecular explanation for the work 
of Spemann and Mangold who had shown 65 years earlier that transplantation of 
dorsal tissue to the ventral region of amphibian embryos resulted in twinned axes 
(Spemann, 1924).  After their discovery of a dorsal head “organizer” 
developmental biologists had struggled for years trying to identify the organizer-
inducing signal emanating from the dorsal tissue.  With the discovery of Wnt and 
its ability to induce a twinned axis, this inducing signal had finally been found and 
made it clear that Wnt signaling has a profound effect on frog development.  
Since then, almost all Wnt pathway components have been validated through 
Xenopus axis specification studies.  
These early studies laid the foundation for further work in multiple model 
systems showing that Wnt signaling plays critical roles in all aspects of 
development and in adult stem cell maintenance (Reya and Clevers, 2005).  
Thus, it is no surprise that misregulation of this pathway results in a variety of 
disease states in humans from birth defects to cancer (MacDonald et al., 2009).  
The most well-characterized link between misregulated Wnt signaling and 
disease is found in colorectal cancer where over 85% of patients have a mutation 
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in adenomatous polyposis coli (APC), a negative regulator of Wnt signaling 
(Kinzler and Vogelstein, 1996).  Mutation of APC results in hyperactive Wnt 
signaling, leading to un-regulated cell growth and tumor formation (the role of 
APC in Wnt signaling will be discussed further below).  In addition to the well-
established role of Wnt signaling in colorectal cancer, numerous other cancer 
types have now been shown to exhibit misregulated Wnt signal transduction, 
including hepatocellular carcinoma, lung cancer, skin cancer, prostate cancer, 
breast cancer, and Wilms’ tumor (Klaus and Birchmeier, 2008; Polakis, 2007). 
Wnt pathway mutations are also known to cause a variety of developmental 
defects including tetra-amelia (defect in limb formation), bone density defects, 
tooth agenesis, and defects in eye vascularization (MacDonald et al., 2009)(see 
also The Wnt Homepage: wnt.standford.edu ).  In order to understand these 
various diseases and to design rational therapies with which to treat them, a 
detailed understanding of the molecular mechanisms of Wnt signal transduction 
is required. 
 
Current Model of Wnt Signaling 
Wnt protein family members are able to activate both “canonical” and 
“non-canonical” Wnt signal transduction pathways.  My work focuses exclusively 
on “canonical,” or β-catenin-mediated, Wnt signaling so I will only discuss this 
pathway.  The key feature of canonical Wnt signaling is the constant synthesis 
and degradation of the main cytoplasmic effector β-catenin (Figure 1.1).  In the  
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absence of a Wnt signal, β-catenin is constitutively degraded by a “β-catenin 
destruction complex” composed of the scaffolds APC and Axin and the kinases 
GSK3 and casein kinase I alpha (CK1α) (Behrens et al., 1998; Gao et al., 2002).  
Within this complex β-catenin is phosphorylated by CK1α at serine 45, which 
primes for GSK3 phosphorylation at serines 33 and 37, and threonine 41 (Amit et 
Figure 1.1.  Schematic of Canonical Wnt Signaling.   
(A) In the absence of Wnt ligand, cytoplasmic β-catenin is bound by the β-catenin 
destruction complex, composed of Axin, APC, CK1α and GSK3.  Within this 
complex, β-catenin is first phosphorylated by CK1α, which primes for GSK3 
phosphorylation.  Phosphorylated β-catenin is recognized by the E3 ligase, SCFβ-
TRCP, which polyubiquitylates β-catenin targeting it for proteasome-mediated 
degradation.  In the nucleus, Wnt target genes are repressed by Groucho/TLE 
and associated HDACs.  (B) In the presence of Wnt ligand, Wnt binds the co-
receptors Fz and LRP5/6, which leads to membrane recruitment of Dvl and Axin.  
Axin-associated GSK3 and CK1α phosphorylate LRP5/6, which inhibits the 
activity of the β-catenin destruction complex.  As a result, β-catenin levels rise in 
the cytoplasm and β-catenin translocates to the nucleus where it binds TCF/Lef to 
activate Wnt target gene transcription.  Figure from (Macdonald et al., 2009). 
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al., 2002; Liu et al., 2002).  Phosphorylated β-catenin is then recognized by the 
E3 ubiquitin ligase Skp1-Cullin-F-box (SCF)β-TRCP, which polyubiquitylates β-
catenin targeting it for degradation by the 26S proteasome (Latres et al., 1999; 
Liu et al., 1999).  Thus, in the absence of a Wnt signal, cytoplasmic levels of β-
catenin are kept low.   
The Wnt family of proteins, for which the pathway is named, are secreted 
lipid-modified glycoproteins that participate in both cell-to-cell communication and 
long-range signaling by acting as morphogens to pattern the development of 
various tissues (MacDonald et al., 2009; Port and Basler, 2010).  At present, 19 
different Wnt family members have been identified in mammals.  Wnts are ~350-
400 amino acids in length and contain an N-terminal signal sequence that targets 
them to the secretory pathway where they are N-linked glycosylated and cysteine 
and serine palmitoylated (Komekado et al., 2007; Takada et al., 2006; Willert et 
al., 2003).  Once secrected, Wnt proteins reach their target cell by way of lateral 
diffusion involving heparan sulfate proteoglycans or via cytoneme projections 
from receptor cells, or can travel up to 20 cell diameters by forming soluble 
micelles, binding soluble lipid-binding proteins, as part of lipoprotein particles, or 
by traveling on exosomes (Port and Basler, 2010).  Wnt proteins can be 
prevented from binding their receptors by a number of secreted molecules.  The 
secreted Frizzled-related protein (sFRP) family of proteins and Wnt inhibitory 
factor (WIF) bind to Wnt and antagonize its ability to interact with Frizzled (Fz) 
(Bovolenta et al., 2008), while the Dickkopf (Dkk) family and Wise/Sclerostin 
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(SOST) family prevent Wnt binding and activation of the co-receptor LDL-
receptor related proteins 5 and 6 (LRP5/6) (Itasaki et al., 2003; Semenov et al., 
2005; Semenov et al., 2001).  Wnt agonists of the Norrin and R-spondin families 
also exist that stimulate Fz-LRP5/6 activity either independent of or in 
coordination with Wnts, respectively (Kazanskaya et al., 2004; Xu et al., 2004).   
Once a Wnt ligand has traversed the extracellular space and avoided any 
potential inhibitors, it will arrive at its target cell where it can bind its two co-
receptors LRP5/6 and Fz, which are both required for pathway activation.  There 
are 10 Fz family members in mammals, which are all seven-pass 
transmembrane receptors, while both LRP5 and LRP6 contain a single 
transmembrane domain (He et al., 2004; Malbon, 2004).  Data generated thus far 
suggest a model in which Wnt binding induces the formation of a LRP5/6-Fz 
complex.  Close association of the two receptors appears to be important as 
synthetically fusing LRP5/6 and Fz together in cultured cells is sufficient to 
activate the pathway (Holmen et al., 2005), but such endogenous receptor 
association upon Wnt stimulation has not been well-established.   
Upon Wnt ligand binding, a key event in LRP5/6 receptor activation is 
phosphorylation of each of its five PPPSPxS motifs found in its intracellular 
domain (Tamai et al., 2004).  Surprisingly, the kinases involved in LRP5/6 
phosphorylation are the same kinases involved in β-catenin degradation:  GSK3 
and CKI, although in this case CKIγ is involved instead of CKIα.  In the case of 
LRP5/6, it is thought that GSK3 serves as the priming kinase by phosphorylating 
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the serine in the PPPSP motifs, which then induces xS phosphorylation by CKIγ 
(Davidson et al., 2005; Zeng et al., 2005).  Thus, GSK3 has both negative and 
positive roles in Wnt signal transduction.  Phosphorylation of the PPPSPxS 
motifs recruits cytoplasmic Axin/GSK3 complexes to LRP5/6 upon Wnt 
stimulation, thus enhancing GSK3-mediated phosphorylation of LRP5/6 
(Davidson et al., 2005; Tamai et al., 2004; Zeng et al., 2005).  Additionally, 
CKIγ also phosphorylates a conserved S/T cluster outside of the PPPSPxS 
motifs in LRP5/6, which induces GSK3 binding (Davidson et al., 2005).  Thus, 
multiple mechanisms exist to recruit additional GSK3 to LRP5/6 in response to 
Wnt stimulation in order to amplify the signal.   
Fz function is required for phosphorylation of LRP5/6 upon Wnt ligand 
binding (Zeng et al., 2008).  In the presence of a Wnt signal, the cytoplasmic 
scaffold Dishevelled (Dsh) becomes phosphorylated and associates with the C-
terminal tail of Fz (Umbhauer et al., 2000; Wong et al., 2003).  As Dsh and Axin 
can interact and polymerize through their DIX domains (Schwarz-Romond et al., 
2007), it has been postulated that Fz-bound Dsh recruits the Axin-GSK3 complex 
to the plasma membrane to initiate LRP5/6 phosphorylation by GSK3 (Zeng et 
al., 2008).  This has led to a model involving both an “initiation” and 
“amplification” step in Wnt signal transduction where Fz recruitment of Dsh and 
the Axin/GSK3 complex functions to initiate a Wnt signal by phosphorylating the 
PPPSPxS motifs and S/T sites in LRP5/6, while the phosphorylated PPPSPxS 
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and S/T-mediated recruitment of more Axin and GSK3 serve to amplify the signal 
(Baig-Lewis et al., 2007).   
 The mechanism by which receptor activation leads to β-catenin 
destruction complex inhibition is not well understood.  Multiple mechanisms have 
been proposed, all of which ultimately result in the inhibition of GSK3’s ability to 
phosphorylate β-catenin.  While dissociation of the destruction complex has been 
proposed as a potential mechanism (Liu et al., 2005a), solid evidence for this is 
lacking and, in fact, recent studies have shown that the complex remains intact 
and co-localizes with Fz and LRP5/6 soon after Wnt stimulation (Bilic et al., 2007; 
Hendriksen et al., 2008; Mao et al., 2001; Yamamoto et al., 2006).  More recent 
evidence suggests that translocation of the entire destruction complex to the 
plasma membrane may lead to direct inhibition of GSK3 activity by LRP5/6 
(Cselenyi et al., 2008; Piao et al., 2008; Wu et al., 2009).  This is consistent with 
the finding that de-phosphorylated β-catenin is present on phosphorylated LRP6-
bound Axin soon after Wnt stimulation (Hendriksen et al., 2008).  Degradation of 
Axin has also been proposed as an important event in β-catenin stabilization 
upon Wnt signaling (Kofron et al., 2007; Tolwinski et al., 2003; Yamamoto et al., 
1999), as Axin is the limiting component in the destruction complex (Lee et al., 
2003).  Thus, affecting Axin levels would be predicted to have a profound effect 
on destruction complex formation.  However, β-catenin is stabilized prior to Axin 
degradation (Liu et al., 2005a; Willert et al., 1999; Yamamoto et al., 1999).  Thus, 
it is likely that GSK3 activity within the destruction complex is rapidly and directly 
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inhibited by LRP5/6 at the membrane upon Wnt ligand binding, and that Axin 
degradation serves as a subsequent step to prevent further destruction complex 
formation.   
 Once the β-catenin destruction complex is inhibited, β-catenin is no longer 
phosphorylated by GSK3 and, thus, no longer ubiquitylated and degraded by 
SCFβ-TRCP.  Consequently, cytoplasmic β-catenin levels rapidly increase due to 
the unopposed constitutive synthesis of β-catenin (Bryja et al., 2007; Liu et al., 
2005a).  Elevated β-catenin translocates to the nucleus through a poorly 
understood process potentially involving the GTPase Rac1 (Wu et al., 2008).  
APC and Axin have been implicated in exporting β-catenin out of the nucleus 
while the co-activators Pygopus and BCL9 (see below) have been implicated in 
nuclear retention of β-catenin, but none of these proteins have been shown to 
affect the rate of export or import indicating they only play roles in the retention, 
and not shuttling, of β-catenin (Cong and Varmus, 2004; Henderson and Fagotto, 
2002; Krieghoff et al., 2006).  Thus, it remains to be determined how β-catenin is 
trafficked in and out of the nucleus.     
Once in the nucleus, β-catenin binds the TCF/Lef family of DNA-binding 
transcription factors to activate Wnt target gene transcription (Arce et al., 2006).  
There are four TCF/Lef family members in mammals:  TCF1, Lef1, TCF3, and 
TCF4.  All TCF/Lef family members bind the consensus sequence CCTTTGWW 
(W indicates either T or A), known as the Wnt responsive element (WRE), found 
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in the promoters of Wnt target genes.  In the absence of a Wnt signal TCF/Lef 
serves as a transcriptional repressor by binding the Groucho/TLE family of 
transcriptional co-repressors.  Groucho is the Drosophila homolog of the human 
transducin-like enhancer of split (TLE) family of proteins, of which there are five:  
TLE1-4 and a truncated isoform named amino-terminal enhancer of split (AES) 
(Gasperowicz and Otto, 2005).  All TLE family members can interact with all 
TCF/Lef family members to mediate repression (Brantjes et al., 2001).  It is 
thought that Groucho/TLE proteins mediate repression by binding to TCF/Lef and 
recruiting histone deacetylases (HDACs), which compress chromatin locally, as 
well as by forming oligomeric structures, which mediate long-range chromatin 
condensation (Buscarlet and Stifani, 2007; Jennings and Ish-Horowicz, 2008).   
The prevailing model for how TCF/Lef is turned from a transcriptional 
repressor into a transcriptional activator involves the direct displacement of 
Groucho/TLE by β-catenin through competition for overlapping binding sites on 
TCF/Lef (Daniels and Weis, 2005).  This model was proposed based primarily on 
in vitro data using purified proteins in which it was found that β-catenin and 
Groucho/TLE bind TCF/Lef in a mutually exclusive manner.  However, this model 
was never tested in vivo.  The work I present in Chapter IV indicates that turning 
TCF/Lef from a repressor into an activator in vivo involves more than a simple 
competition between β-catenin and Groucho/TLE.  I provide evidence indicating 
that mono-ubiquitylation of Groucho/TLE by the E3 ubiquitin ligase XIAP is 
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required to remove Groucho/TLE from TCF/Lef to allow β-catenin-TCF/Lef 
complex formation and Wnt-mediated transcriptional activation.  
Upon TCF/Lef binding, β-catenin nucleates a transcriptional activation 
complex consisting of Pygopus, BCL9, p300/CBP and TRRAP/TIP60 histone 
acetyltransferases, MLL1/2 histone methyltransferases, the SWI/SNF family of 
ATPases for chromatin remodeling, Mediator for transcription initiation, and the 
PAF1 complex for transcription elongation and histone modifications (Mosimann 
et al., 2009; Willert and Jones, 2006).  This β-catenin-mediated multi-protein 
complex functions to activate the transcription of an estimated 300-400 Wnt 
target genes, which regulate many cellular processes including cell survival, 
proliferation, and differentiation (Hatzis et al., 2008).  In addition to β-catenin’s 
role as a transcriptional activator, recent evidence indicates that β-catenin-
TCF/Lef complexes can function as transcriptional repressors by binding to both 
canonical WREs and to a novel TCF binding element, AGAWAW (Blauwkamp et 
al., 2008; Theisen et al., 2007).  To add even more complexity to β-catenin-
mediated transcriptional regulation, it has been shown that β-catenin can interact 
with a number of other DNA-binding transcription factors besides TCF/Lef to 
activate or repress transcription of even more genes (e.g. Smad4, MyoD, c-Jun, 
and RAR, among many others) (MacDonald et al., 2009).  Thus, it is clear that 
Wnt-mediated β-catenin stabilization and nuclear translocation has a profound 
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effect on total cellular gene expression and, thus, on the overall physiology of the 
cell; most of which remains to be discovered. 
 
Historical Perspective:  The Ubiquitin System 
The discovery of the ubiquitin system highlights the importance of asking 
basic, and sometimes unpopular, questions in scientific discovery, such as:  how 
do proteins degrade in the cell?  In the decades prior to the discovery of the 
ubiquitin system, most scientists were fascinated by the discovery of DNA and 
how genes are transcribed and translated into proteins, while very little attention 
was paid to the stability of proteins once they had been synthesized. At that time, 
it was generally thought that proteins were long-lived, static molecules.  Thus, 
very few scientists were interested in, or even believed in, the concept of protein 
degradation (Ciechanover, 2009; Varshavsky, 2006).  Afterall, why would the cell 
expend so much energy to synthesize a protein just to degrade it?  The idea that 
proteins might be in a dynamic state of synthesis and degradation was first 
proposed about 70 years ago when Rudolf Schoenheimer showed that only 50% 
of the 15N-labeled tyrosine he administered to rats was recovered in the urine, 
and that the rest had been deposited in the rat’s tissues, indicating that protein 
synthesis had occurred.  Additionally, he found an equivalent amount of protein 
nitrogen excreted, indicating, for the first time, that protein degradation had taken 
place in the rat (Schoenheimer, 1942).   
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The idea that proteins turn over was not well accepted until the discovery 
of the lysosome in the mid-1950s (De Duve et al., 1953; Gianetto and De Duve, 
1955).  After the discovery of the lysosome, it was assumed that all proteins were 
degraded in this cellular compartment, but three important discoveries indicated 
the existence of non-lysosomal-mediated protein degradation:  1.)  Differing 
protein half-lives, as it was predicted that proteins degraded by lysosomal 
proteases should be degraded at the same rate, but this was not found to be the 
case (Goldberg and St John, 1976; Schimke and Doyle, 1970), 2.) The fact that 
proteins were still degraded in the presence of lysosomal inhibitors, indicating 
there must be an alternative mode of protein degradation in the cell (Knowles 
and Ballard, 1976; Neff et al., 1979), and 3.) A paradoxical energy requirement 
for protein degradation, which was not expected to be necessary for lysosomal 
protease-mediated protein degradation (Mandelstam, 1958; Simpson, 1953; 
Steinberg and Vaughan, 1956).  Regardless of these obvious inconsistencies, 
most scientists still believed that proteins were degraded in the lysosome and 
that the mystery of protein degradation had been solved by the discovery of this 
intracellular organelle. 
A big breakthrough in support of non-lysosomal-mediated protein 
degradation came when Rabinovitz and Fisher observed that abnormal 
hemoglobin is degraded in rabbit reticulocytes, which do not contain lysosomes 
(Rabinovitz and Fisher, 1964).  Subsequently, two groups independently 
prepared cell-free rabbit reticulocyte lysates in which they showed degradation of 
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abnormal hemoglobin was ATP-dependent and occurred optimally at neutral pH 
(unlike in the lysosome where protein degradation occurs optimally at an acidic 
pH) (Etlinger and Goldberg, 1977; Hershko, 1978).  It was with this newly 
prepared rabbit reticulocyte lysate that Aaron Ciechanover, Avram Hershko and 
Irwin Rose performed their Nobel-Prize winning experiments in which they 
purified and characterized all of the main components of the hitherto unidentified 
“ubiquitin system” (described in more detail below): the small protein ubiquitin 
that is covalently attached to substrate proteins by a sequence of events 
involving an E1 (activating enzyme), E2 (conjugating enzyme), and E3 (ligating 
enzyme), as well as ubiquitin hydrolases, which cleave ubiquitin from target 
proteins (reviewed in (Ciechanover, 2009; Varshavsky, 2006)).  These initial 
discoveries, along with the many others that followed, proved unequivocally that 
protein degradation occurs outside of lysosomes in a very complex and highly 
regulated manner.  We are just beginning to understand the immense impact of 
this groundbreaking work.   
 
Current Model of The Ubiquitin System 
We now know the ubiquitin system regulates many fundamental cellular 
processes including the cell cycle, endocytosis, the immune response, 
development, and cell signaling pathways.  This broad regulation occurs through 
“ubiquitylation” of proteins, a term which refers to the post-translational 
modification of proteins in which the small (76 amino acid), highly conserved 
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protein ubiquitin is covalently attached to target proteins in the form of monomers 
or polymers.  The addition of ubiquitin to target proteins changes the activity, 
localization, or stability of the target protein depending on which type of ubiquitin 
modification is added (reviewed in (Hershko and Ciechanover, 1998; Pickart, 
2001, 2004)). 
 Three enzymes catalyze the process of ubiquitin conjugation in sequence 
(Figure 1.2) (reviewed in (Hershko and Ciechanover, 1998; Pickart, 2001, 2004)).  
First, an E1 activating enzyme activates ubiquitin in an ATP-dependent manner 
and subsequently forms a thiolester bond between a cysteine residue in its active 
site and the carboxy-terminal glycine residue of ubiquitin.  Next, the E1 catalyzes 
the transfer of the ubiquitin molecule to the active site cysteine of an E2 
conjugating enzyme.  Finally, the E2 catalyzes the transfer of ubiquitin from itself 
onto a lysine residue of the target protein by way of an E3 ubiquitin ligase.  There 
are between several hundred to over a thousand E3 ligases in the human 
genome that fall into one of two major families: the Really Interesting New Gene 
(RING) and Homologous to E6AP Carboxy Terminus (HECT) families.  RING 
E3s catalyze the transfer of ubiquitin from the E2 to the target protein by serving 
as bridges to bring the lysine residue of the target protein close to the E2-
ubiquitin intermediate, thereby increasing the probability of reaction.  HECT E3s 
form a thiolester intermediate with ubiquitin before it is transferred to the target 
protein (Pickart and Eddins, 2004).  Once one ubiquitin molecule has been 
covalently attached to a lysine residue on the target protein, multiple ubiquitin 
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molecules can be added in succession through a poorly understood mechanism 
to produce a ubiquitin polymer consisting of many covalently-linked ubiquitin 
molecules (polyubiquitylation) (Hochstrasser, 2006). 
 
 
Ubiquitin contains seven internal lysine residues, each of which can be 
used for ubiquitin conjugation resulting in the formation of different lysine-linked 
ubiquitin chains (K6, K11, K27, K29, K33, K48, K63) (Behrends and Harper, 
2011; Peng et al., 2003).  The best understood polymer is the K48-linked 
ubiquitin chain, which typically marks the target protein for degradation by the 
26S proteasome (Thrower et al., 2000).  K63-linked chains typically do not mark 
a protein for proteasomal degradation, but rather activate specific proteins for 
Figure 1.2.  Schematic of the ubiquitin system.  Figure adapted from 
(Dikic et al., 2009).   
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DNA repair, signal transduction, endocytosis, etc. (Pickart and Fushman, 2004; 
Sun and Chen, 2004).  Target proteins can also be covalently attached to a 
single ubiquitin molecule at one lysine residue (monoubiquitylation) or at multiple 
lysine residues (multi-monoubiquitylation), resulting in different effects on target 
protein function such as regulating sub-cellular localization or the recruitment of 
ubiquitin-binding proteins (d'Azzo et al., 2005; Welchman et al., 2005).    
 The process of ubiquitin conjugation can be reversed by cleavage of the 
isopeptide bond between ubiquitin and the lysine residue of the target protein by 
deubiquitylating enzymes (DUBs) (Figure 1.2).  This results in the release of free 
ubiquitin and free enzyme and reverses the effects of the ubiquitin modification 
(reviewed in (Amerik and Hochstrasser, 2004; Komander et al., 2009; Nijman et 
al., 2005)). There are approximately 79 functional DUBs in the human genome, 
most of which are cysteine proteases that contain a highly conserved cysteine 
residue in their active sites.  DUBs fall into one of five subclasses based on their 
ubiquitin-protease domains:  ubiquitin-specific proteases (USPs, 58 total), 
ubiquitin C-terminal hydrolases (UCHs, 4 total), Otubain proteases (OTUs, 14 
total), Machado-Joseph disease proteases (MJDs, 5 total), and one class of 
metalloproteases called JAMM (JAB1/MPN/Mov34 metalloenzyme, 14 total).  It is 
thought that DUBs regulate a limited number of substrates by recognizing either 
specific ubiquitin polymers or monomers (substrate specificity) and/or the target 
protein to which the ubiquitin moiety is attached (target specificity), giving DUBs 
two mechanisms by which to target specific sets of proteins (Nijman et al., 2005).   
 23 
 According to the current ubiquitin system model, the two enzymes that 
confer substrate specificity to the system are the E3 ligases and the DUBs.  
Thus, it is these two classes of enzymes that are likely to play specific roles in 
regulating cellular functions.  Indeed, many E3s and DUBs have now been 
identified as key Wnt signaling regulators.    
 
Regulation of Wnt signaling by The Ubiquitin System 
Ubiquitylation plays a critical role in regulating Wnt signal transduction, 
most notably by regulating cytoplasmic levels of β-catenin, the key component of 
the pathway.  The first E3 ubiquitin ligase (E3) identified for β-catenin was the 
multi-subunit E3 Skp1-Cullin-F-box (SCF)β-TRCP, which recognizes phosphorylated 
β-catenin in the β-catenin destruction complex and targets it for proteasomal 
degradation (Aberle et al., 1997; Jiang and Struhl, 1998).  Thus, SCFβ-TRCP is 
critical for keeping cytoplasmic levels of β-catenin low in the absence of a Wnt 
signal.  More recent findings indicate the existence of an additional E3 for β-
catenin, Siah-1, which mediates K11-linked polyubiquitylation of β-catenin upon 
genotoxic stress (Liu et al., 2001; Matsuzawa and Reed, 2001).  In response to 
DNA damage, it is thought that activated p53 induces the expression of Siah-1, 
which can ubiquitylate β-catenin independent of its phosphorylation status and 
independent of SCFβ-TRCP.  Thus, it appears that cytoplasmic levels of β-catenin 
can also be directly affected by cellular stress through upregulation of Siah-1.  
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Jade-1 is an additional recently discovered E3 for β-catenin that appears to 
mainly regulate its nuclear levels (Chitalia et al., 2008).  Like SCFβ-TRCP, Jade-1 
only recognizes GSK3-phosphorylated β-catenin, but unlike SCFβ-TRCP Jade-1 
functions mostly in the nucleus and ubiquitylates β-catenin in both the absence 
and presence of Wnt signaling.  At present Jade-1 mediated β-catenin regulation 
has only been observed in kidney tissues.  It remains to be determined if this is a 
more general Wnt signaling regulatory mechanism.  
In addition to the critical regulation of β-catenin levels by ubiquitylation, the 
two β-catenin destruction complex scaffolding proteins Axin and APC are also 
both regulated by the ubiquitin system.  As discussed above, various groups have 
observed Axin degradation and, because it is a limiting component in the β-
catenin destruction complex, Axin degradation has been proposed to be a critical 
Wnt signaling event.  Until recently, however, the proteins involved in regulating 
Axin stability remained elusive.  Axin was first shown to be parsylated by 
tankyrase 1 and 2, which was determined to be required for its ubiquitylation and 
degradation (Huang et al., 2009a).  Subsequently a DUB, USP34, was discovered 
to regulate Axin stability, presumably by reversing the effects of an E3 ubiquitin 
ligase that had not been identified (Zhang et al., 2011).  Just recently, an E3 
ligase for Axin was discovered, RNF146, which recognizes parsylated Axin and 
targets it for proteasomal degradation (Zhang et al., 2011).  Thus, three key 
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components for regulating Axin levels have been identified indicating regulating 
Axin stability is a critical event in Wnt signal transduction.    
It has been known for some time that APC is ubiquitylated and degraded 
by the proteasome (Choi et al., 2004), but no E3 for APC has been identified.  
Recently the DUB, USP15, has been implicated in protecting APC from 
degradation as part of the COP9 signalasome (CSN) (Huang et al., 2009b).  The 
CSN has been reported to bind to SCFβ-TRCP to enhance its activity towards 
phosphorylated β-catenin.  Thus, it appears that USP15 functions to stabilize APC 
in the destruction complex to allow for efficient degradation of β-catenin via the 
combined effects of CSN and SCFβ-TRCP.  Another DUB, Trabid, has been shown 
to interact with and to remove K63-linked polyubiquitin chains from APC, although 
the functional consequence of both the addition of K63-linked chains to APC and 
their removal remains to be determined (Tran et al., 2008).   
Wnt signaling events at the plasma membrane are also regulated by 
ubiquitylation.  Most notably, the amount of the two co-receptors, LRP5/6 and Fz, 
available for initiation of Wnt signaling on the cell surface are regulated by 
components of the ubiquitin system.  In the case of LRP5/6, mono-ubiquitylation 
serves as a quality control step to ensure the receptor is palmitoylated and 
properly folded before it exits the endoplasmic reticulum (ER) (Abrami et al., 
2008).  If LRP5/6 is not palmitoylated it becomes mono-ubiquitylated and retained 
in the ER.  Neither the E3 that adds the mono-ubiquitin moiety onto LRP5/6 or the 
DUB that removes it have been identified.  Recent work showed that Fz is also 
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modified by ubiquitin conjugation; a modification that results in translocation of Fz 
to the lysosome where it is degraded (Mukai et al., 2010).  Mukai and colleagues 
identified a DUB, USP8, that removes the ubiquitin modification from Fz to 
prevent its lysosomal targeting and degradation, thereby increasing the amount of 
Fz on the cell surface available for Wnt signaling.  The E3 ligase that targets Fz 
for lysosomal degradation remains to be identified.    
Downstream of the two co-receptors lies the cytoplasmic protein Dsh, 
which has been shown to be ubiquitylated by the Kelch-like 12 (KLHL12)-Cullin3 
E3 ligase complex in response to Wnt stimulation (Angers et al., 2006).  
Ubiquitylation of Dsh by KLHL12 leads to its proteasomal degradation.  Thus, 
KLHL12 serves as a negative regulator of Wnt signaling.  In addition to its 
regulation by KLHL12, Dsh is also regulated by K63-linked polyubiquitylation, 
which appears to positively regulate Dsh function in the Wnt pathway.  The K63-
linked ubiquitin chains are removed by the DUB CYLD (Tauriello et al., 2010); a 
process that inhibits Wnt signaling.  It remains to be determined which E3 
conjugates the K63-linked polyubiquitin chains onto Dsh and what effect this 
modification has on Dsh activity.   
Clearly, the ubiquitin system is intimately involved in regulating Wnt signal 
transduction.  Although numerous E3s and DUBs have now been identified as 
key Wnt regulators, at the time I began my thesis work only the E3 ligases for β-
catenin (SCFβ-TRCP) and Dsh (KLHL12-Cullin3) had been identified. No other E3s 
or DUBs had been identified for the other components of the pathway that were 
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known to be ubiquitylated.  Thus, I performed a targeted RNAi screen in 
Drosophila S2 cells to identify novel E3 ligases and DUBs involved in the 
regulation of Wnt signal transduction, which I describe in Chapter III.  
Identification and characterization of novel E3 ligases and DUBs involved in Wnt 
signaling will greatly enhance our understanding of how this important pathway is 
regulated by the complex ubiquitin system and potentially lead to the design of 
novel therapeutics with which to treat Wnt-driven diseases.    
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Drosophila dsRNA Generation and S2 Cell RNAi Screen 
Verified or predicted E3 ligases were identified using the “Termlink” function on 
www.flybase.org. The following search terms were used: ubiquitin protein ligase 
activity, E3, and ubiquitin ligase complex. We pooled the search results to give a 
final list of 146 E3 ligases, of which we were able to screen a subset of 122 of 
these clones. We used the Drosophila Gene Collection (DGC) to isolate plasmid 
cDNAs encoding each E3 ligase (see Figure 3.1A). T7 and T3 RNA polymerase 
promoters were added to the 5’ and 3’ end of each cDNA, respectively, via PCR 
using primers specific for the vector, similar to the methods described in 
(Clemens et al., 2000). Primer sequences are as follows for E3 ligases in 
pOTB7/pOT2: Forward-5’-
CAGAGATGCATAATACGACTCACTATAGGGAGATTAGGTGACACTATAGAAC
T-3’, Reverse-5’-
CCAAGCCTTCAATTAACCCTCACTAAAGGGAGAAAGCCCGCTCATTAGGCG
GGTTAAA-3’ 
For E3 ligases in pBSSK/pFlc1: Forward-5’-
CAGAGATGCATAATACGACTCACTATAGGGAGACGACTCACTATAGGGCGA
AT-3’, Reverse-5’-
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CCAAGCCTTCAATTAACCCTCACTAAAGGGAGATTAACCCTCACTAAAGGGA
ACAAAA-3’.  
dsRNA was synthesized in an in vitro transcription reaction using mMessage 
mMachine (Ambion) according to manufacturer’s instructions using T3 and T7 
RNA polymerases, purified using RNeasy Mini Kit (Qiagen), and added to 
Drosophila S2 reporter cells stably transfected with a Wg TOPflash luciferase 
transcriptional reporter and a vector containing a constitutively expressed LacZ 
gene (gift from R. Nusse, Stanford). The S2 reporter cells were incubated with 
dsRNA for 72 hrs prior to incubation for 24 hrs in Wg-conditioned media.  Cells 
were lysed in 1X Passive Lysis Buffer (Promega), and luciferase and β-
galactosidase activities were measured using Steady Glo and β-Glo Assays 
(Promega), respectively. Luciferase activity was normalized to β-galactosidase 
activity (a measure of cell number).   
 
Plasmids and Purified Proteins 
pCS2-XIAP, pCS2-myc-XIAP, pCS2-HA-XIAP, pCS2-myc-cIAP1, pCS2-myc-
cIAP2, pCS2-myc-TLE3, pCS2-myc-TLE3-Q, pCS2-myc-TLE1, pCS2-myc-AES, 
pCS2-HA-SMAC, and pMAL-XIAP, pCS2-USP47, pCS2-USP47mut, pCS2-GFP-
USP47, were all generated using standard PCR-based cloning strategies. The 
following plasmids were purchased from Addgene and described previously 
(Lewis et al., 2004; Yang et al., 2000): pEBB-XIAP, pEBB-XIAPΔRING (1-351), 
pGEX-XIAP, pGEX-XIAPΔRING.  The following plasmids were generous gifts: 
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pEBB-XIAPcasp-mut (D148A/W310A) (C. Duckett, University of Michigan), 
pMT107 (His-Ub) (W. Tansey, Vanderbilt University), pMP-SUMO-H6-Groucho-Q 
(A. Courey, UCLA), pGEX-TCF4 (J. Eid, Vanderbilt University), pcDNA3-HA-
TLE3 (A. Kispert, Hannover Medical School), pHR-myc-β−TRCP-1 (S. Elledge, 
Harvard Medical School), pCMV-Script-Smad4 (D. Beauchamp, Vanderbilt 
University) and TP1-Luc and NotchICV (S. Huppert, Vanderbilt University). TK-
Renilla (Promega) and TOPflash (Korinek et al., 1997) were described 
previously. GST-XIAP, GST-XIAPΔRING (Lewis et al., 2004), SUMO-H6-
Groucho-Q (Kuo et al., 2010), and GST-TCF4 (Poy et al., 2001) were purified as 
described previously. MBP-XIAP was expressed in bacteria and purified 
according to manufacturer’s instructions (New England Biolabs).  
 
Cell Lines and Transfections 
HEK293, HeLa, SW480, and L and L-Wnt3a cell lines were purchased from the 
American Type Culture Collection. Wg-secreting cells were purchased from the 
Drosophila Genomics Resource Center. HEK293 CMV-Luc was reported 
previously (Thorne et al., 2010). The following cell lines were gifts: HEK293 STF 
(J. Nathans, Johns Hopkins University), HCT116 XIAP WT and HCT116 XIAP 
KO (B. Vogelstein, Johns Hopkins University), S2 reporter cells (R. Nusse, 
Stanford University). Mammalian cell lines were cultured in DMEM plus 10% (v/v) 
FBS and antibiotics. Drosophila S2 cells were cultured in Schneider's medium 
plus 10% (v/v) FBS. DNA transfections were performed with Lipofectamine 2000 
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transfection reagent (Invitrogen) according to the manufacturer’s protocol. siRNA 
transfections were performed using Dharmafect-1 (HEK293 and HeLa cells) or 
Dharmafect-4 (HCT116 and SW480 cells) according to the manufacturer’s 
protocol with the following siRNA constructs: XIAP siRNA#1: 5’-
AAGUGGUAGUCCUGUUUCAGCUU-3’, XIAP siRNA#2: 5’-
GGUAAGAACUACUGAGAAAUU-3’, USP47 siRNA#1:  5’-
UUGUUCACCAUCUUUAUCUdTdT-3’,  
USP47 siRNA#2: 5’-AAAUGCUAUAGCUUUCUUCdTdT-3’,  
or siGENOME Non-Targeting siRNA #5 (Thermo Scientific Dharmacon). 
 
Reporter Assays 
For cell-based luciferase assays, cells were plated and transfected with siRNA or 
DNA, as described above. L cell-conditioned media or Wnt3a-conditioned media 
was added to HEK293 STF cells 24 hrs after transfection. Cells were lysed 48 
hrs after transfection with 1X Passive Lysis Buffer (Promega) and luciferase 
activity measured with Steady Glo (Promega). Luciferase activities were 
normalized to viable cell number using the CellTiter-Glo Assay (Promega). 
TOPflash experiments in HCT116 and SW480 cells were normalized to co-
transfected Renilla gene expression. TP1 reporter assay was performed in 
HEK293 cells as previously described (Huppert et al., 2005). All graphs were 
made using Prism 4 (GraphPad Software, Inc.). Statistical analysis was 
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performed using the Student's t test. A value of p < 0.05 is considered statistically 
significant. 
 
Ubiquitylation Assays 
In vitro ubiquitylation assays were carried out in 20 ul reactions using the 
Ubiquitin Thioester/Conjugation Initiation Kit (Boston Biochem) and the following: 
1 uM UbcH5a (Boston Biochem); 2.5 ug GST-XIAP, GST-XIAPΔRING, or MBP-
XIAP; and 1 mM DTT. In vitro-translated myc-TLE3 or HA-TCF4 or recombinant 
SUMO-H6-Groucho-Q were used as substrates. Reactions were carried out at 
30°C for 90 min and stopped by addition of sample buffer. Reaction products 
were resolved by SDS/PAGE and visualized by immunoblotting. In vivo 
ubiquitylation assays were performed using the His-tagged ubiquitin method as 
previously described (Salghetti et al., 1999). 
 
Gel Filtration 
Gel filtration was performed using an AKTA FPLC apparatus with Superose 6 or 
Superdex 200 columns (GE Healthcare). The following standards were used for 
calibration: thyroglobulin (670 kDa), γ-globulin (158 kDa), ovalbumin (44 kDa), 
myoglobin (17 kDa), and vitamin B12 (1.35 kDa) (Bio-Rad). In vitro-translated and 
ubiquitylated myc-TLE3 and myc-TLE3-Q were chromatographed at 4°C in 
50 mM Tris (pH 7.4) and 200 mM NaCl, as described previously for SUMO-H6-
Groucho-Q (Kuo et al., 2010). 
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Antibodies 
The following antibodies were used for immunoprecipitation, immunoblotting and 
immunofluorescence: anti-β-catenin (BD Transduction Labs), anti-GAPDH 
(Abcam), anti-HA (3F10, Roche), anti-XIAP (R&D Systems (immunoprecipitation) 
and BD Transduction (immunoblotting)), anti-TLE3 (M-201, Santa Cruz), anti-
Myc (9E10), anti-TCF4 (Cell Signaling Technologies), anti-Flag (M2, Sigma), 
anti-His (Novagen), anti-USP47 (Bethyl), anti-β-TRCP (Zymed, 37-3400), and 
anti-Smad4 (Santa Cruz, sc7966). 
 
Immunoblots, Immunoprecipitations, and GST Pull-Downs 
For immunoblots, cells were lysed in non-denaturing lysis buffer (NDLB) (50 mM 
Tris-Cl (pH 7.4), 300 mM NaCl, 5 mM EDTA, 1% (w/v) Triton X-100, protease 
inhibitor cocktail (Roche)) and soluble fractions were obtained. For cycloheximide 
(CHX)-chase experiments, cells were treated with 50 ug/ml CHX for the indicated 
time. For co-immunoprecipitations, cells were lysed in NDLB supplemented with 
250 ng/ml ubiquitin aldehyde. Lysates were diluted to 1 mg/ml with NDLB and 
incubated with antibody O/N with rotation at 4°C followed by addition of Protein 
A/G beads (Santa Cruz) for 2 hrs. Beads were then washed five times with 
NDLB. Bound proteins were eluted from beads with protein sample buffer and 
analyzed by SDS-PAGE/immunoblotting. For in vitro binding assays, GST or 
GST-TCF4-bound glutathione beads were diluted into binding buffer (20 mM 
Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% NP-40, 1 mM DTT, and protease inhibitor 
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cocktail) and incubated with in vitro translated myc-TLE3 or myc-TLE-Q or 
recombinant MBP-XIAP for 2 hrs with rotation at 4°C. Beads were washed five 
times for 10 min at RT in binding buffer, and proteins eluted with sample buffer 
and analyzed by SDS-PAGE/immunoblotting. 
 
Xenopus laevis Studies 
Xenopus embryos were in vitro fertilized, dejellied, cultured, and injected as 
previously described (Peng, 1991).  Morpholinos with the following sequences 
were purchased from Gene Tools. Standard Control MO: 5’-
CCTCTTACCTCAGTTACAATTTATA-3’, XIAP MO#1: 5’-
GCATGTCATCTCCTCTTTAAATACG-3’, XIAP MO#2: 5’-
GGAACCACAACCTTCCTACCGGCTC-3’, USP47 MO:  5’-
GCTGACTCTCTTCTCCAGGCCTCAT-3’.  Capped Xwnt8, XIAP, and USP47 
mRNA were generated using mMessage mMachine (Ambion) according to 
manufacturer’s instructions. Animal caps were excised from stage 9 embryos, 
cultured until stage 11, and RT-PCR of Siamois, Xnr3, Chordin, and ODC 
transcripts was performed as described (Cselenyi et al., 2008).  In situ 
hybridization analysis was performed as described (Harland, 1991) using a probe 
against Xenopus USP47 using Sp6 polymerase for the antisense strand.  For 
whole embryo sectioning and staining, embryos were formalin fixed, processed, 
embedded into paraffin and stained with hematoxylin and eosin for histological 
analysis.  Statistical analysis was performed using the Fisher’s exact test. A 
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value of p < 0.05 is considered statistically significant. All the work performed on 
Xenopus embryos was approved by the Institutional Animal Care and Use 
Committee (IACUC) at Vanderbilt University Medical Center and was in 
accordance with their policies and guidelines. 
 
Immunofluorescence 
Cells were grown on fibronectin-coated coverslips, fixed in 3.7% formaldehyde, 
permeabilized, incubated with primary antibody (anti-myc 1:1000, anti-XIAP 
1:200, anti-TLE3 1:200, anti-β-catenin 1:1000) followed by secondary antibodies 
conjugated to Cy3 or Alexa 488, and mounted in ProLong Gold with DAPI 
(Invitrogen). Cells were visualized using a Cascade 512B camera mounted on a 
Nikon Eclipse TE2000-E confocal microscope. 
 
Real-Time RT-PCR 
HEK293 cells were transfected with siRNA as described above and incubated for 
24 hrs. Cells were then serum starved (0.5% FBS) for 16 hrs and incubated with 
Wnt3a-CM for 24 hrs. Total RNA was isolated using RNAeasy RNA extraction kit 
(Qiagen) and cDNA generated using High Capacity cDNA Reverse Transcription 
kit (Applied Biosystems, ABI). Real-time RT-PCR assays were performed in 
quadruplicate using TaqMan Gene Expression Master Mix (ABI), gene specific 
TaqMan TAMRA probes (ABI), and an ABI 7000 sequence detection system. 
The following AXIN2 primer sequences were used. Forward: 5’-
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GTCCAGCAAAACTCTGAGGG-3’, Reverse: 5’-CTGGTGCAAAGACATAGCCA-
3’.  
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CHAPTER III 
 
RNAi SCREEN TO IDENTIFY NOVEL UBIQUITIN SYSTEM COMPONENTS 
INVOLVED IN WNT SIGNALING 
 
Introduction 
 As I discussed in Chapter I, the Wnt signaling pathway is heavily regulated 
by ubiquitylation, but not many of the ubiquitin system components (i.e. E3 
ligases and DUBs) involved in Wnt pathway regulation had been identified at the 
time I began my graduate studies.  Thus, I designed a RNA interference (RNAi) 
screen in Drosophila S2 cells to identify novel E3s and DUBs involved in Wg/Wnt 
signaling.  RNAi is a potent method for knocking down expression of specific 
mRNA molecules.  This approach has been well established using the 
Drosophila S2 cell system (Clemens et al., 2000; Goshima et al., 2007), which 
has many advantages:  1) there are fewer genes in Drosophila than in 
mammalian systems, simplifying the screen; 2) uptake of dsRNA is very robust in 
S2 cells and does not require use of a transfection reagent; and 3) Drosophila 
dsRNA can be synthesized in the laboratory using Drosophila Gene Collection 
cDNA clones (which we have in our laboratory) and adding a second T7 
polymerase promoter (within the primer) via PCR to generate full-length dsRNA 
for each gene of interest.  This generally results in very efficient knockdown of 
target gene expression.   
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Thus, I designed a RNAi screen targeting all of the predicted E3 ligases 
and DUBs in the Drosophila genome (see Chapter II for details).  I used the 
Drosophila Gene Collection to collect plasmid cDNAs encoding each DUB and 
E3 ligase.  An additional T7 RNA polymerase promoter was added to the 3’ end 
of the reverse strand of each cDNA via PCR, and dsRNA was synthesized in an 
in vitro transcription reaction using T3 and T7 RNA polymerases (Figure 3.1).  
The dsRNA was then purified and added to Drosophila S2 reporter cells 
(obtained from R. Nusse, Stanford University), which have been stably 
transfected with the well-characterized TOPflash luciferase transcriptional 
reporter and with a vector containing a constitutively expressed LacZ gene.  The 
TOPflash reporter contains 8 TCF/LEF binding sites upstream of a minimal 
promoter, which drives expression of luciferase (Korinek et al., 1997).  In these 
S2 reporter cells, luciferase activity is a measure of Wg signaling activity that can 
be normalized to β-galactosidase activity, which is a measure of cell number.  
The dsRNA was incubated with the S2 reporter cells for 72 h at which time Wg 
(the Drosophila Wnt homolog)-conditioned media was added to the cells in a 1:1 
ratio.  The cells were incubated for an additional 24 h, lysed, and luciferase and 
β-galactosidase activity were measured.  Luciferase activity was then normalized 
to β-galactosidase activity to obtain the final results.  
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Results 
 
Results of the Drosophila E3 ligase RNAi screen 
In both the E3 ligase and DUB RNAi screen, Axin (a potent negative 
regulator of Wg signaling) and Armadillo (Arm, the Drosophila β-catenin homolog 
and potent positive regulator of Wg signaling) dsRNA served as controls to 
confirm effective knockdown in each experiment.  Both the Axin and Arm controls 
are shown in Figure 3.2A, but the Axin control is not shown in the rest of the 
figures to make it easier to visualize differences between the samples treated 
with dsRNA targeting the E3s and the Wg-treated samples.  Axin control dsRNA 
Figure 3.1.  Schematic of Drosophila RNAi screen to identify E3 ligases 
and DUBs involved in regulating Wg/Wnt signlaling.  See text and 
Chapter II (Materials and Methods) for details.   
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significantly increased Wg signaling, while Arm control dsRNA significantly 
decreased Wg signaling in all samples, indicating that the dsRNA treatment was 
effective.    
Of the 118 E3 ubiquitin ligases screened (Table 3.1 and Figure 3.2), the 
knockdown of one (number 112) was particularly potent in inhibiting Wg 
signaling, reducing TOPflash activity to a similar extent as knocking down Arm. 
dsRNA number 112 targets Drosophila Inhibitor of Apoptosis 1 (DIAP1), a well-
characterized anti-apoptotic effector and a member of the evolutionarily 
conserved Inhibitor of Apoptosis protein (IAP) family (Srinivasula and Ashwell, 
2008). I chose to pursue this “hit” further because it suggested an unexpected 
link between a classic IAP family member and regulation of the Wg signaling 
pathway.  This result is described in detail in Chapter IV.   
In addition to E3 number 112, two other interesting “hits” were recovered.  
One of these was number 52, which corresponds to the Drosophila gene 
Trithorax (Trx) (Figure 3.2E).  Knockdown of Trx activates Wg signaling, 
indicating it is a negative Wg signaling regulator in S2 cells, however, the human 
homolog of Trx  (Mixed-Lineage Leukemia (MLL), a methyltransferase) has now 
been shown to associate with β-catenin to promote histone H3 lysine 4 (H3K4) 
methylation to activate Wnt target gene transcription (Sierra et al., 2006).  The 
discrepancy between my data and the data of Sierra et al. could simply be due to 
differences in regulation of Wg/Wnt signaling in Drosophila versus human cells.  
Additionally, it is not clear how a methyltransferase was included in the predicted 
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E3 ligase list obtained from www.flybase.org (see Chapter II for details).  It may 
be due to the fact that MLL contains a zinc finger domain, which is found in RING 
domain-containing E3 ligases.  Regardless of the fact that MLL is not an E3 
ligase and that my data indicates its fly homolog is a negative Wg signaling 
regulator, the fact that knockdown of the gene affected Wg activity validated that 
I was able to identify Wg signaling regulators using this method.  
The other interesting “hit” was E3 number 106, which corresponds to the 
Drosophila gene Something That Sticks Like Glue (SNAMA), whose human 
homolog is Retinoblastoma Binding Protein 6 (RBBP6).  My results indicate 
SNAMA/RBBP6 is a negative regulator of Wg/Wnt signaling as its knockdown 
activates TOPflash activity (Figure 3.2H).  Nothing has been published indicating 
a role for SNAMA/RBBP6 in Wg/Wnt signaling to date.  The few studies that 
have been published on RBBP6 have failed to reach a conclusion regarding its 
function, but it has been strongly implicated in tumorigenesis and is required for 
development; two roles which have largely been attributed to its capacity to bind 
the tumor suppressor proteins p53 and pRB (Li et al., 2007; Motadi et al., 2011; 
Rowe et al., 2006; Simons et al., 1997).  Interestingly, it has recently been 
predicted to be a transcriptional repressor, which is consistent with my data 
indicating it represses Wg signal transduction (Peidis et al., 2010).  It will be 
interesting to determine if RBBP6 acts as a transcriptional repressor in the Wnt 
pathway and how this may or may not be influenced by its interaction with p53 or 
pRB.      
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There were other E3 ligases screened that affected Wg signaling either 
positively or negatively, but many do not have obvious human homologs.  It will 
be interesting to see how many of them turn out to be bona fide Wnt signaling 
regulators. 
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Figure 3.2.  Results of Drosophila E3 ligase RNAi screen for 
Wg/Wnt signaling regulators.   
(A-I)  Results of TOPflash activity normalized to β-galactosidase 
activity relative to –Wg treatment.  Mean ± standard deviation (SD) 
of each dsRNA treatment performed in triplicate is shown.  Axin (A 
only) and Arm serve as controls for negative and positive 
regulators of Wg/Wnt signaling, respectively.  Asterisk indicates 
the most potent “hit” identified in the screen, which is described 
further in Chapter IV.      
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E3 Collection # FULL NAME SYMBOL CLONE ID PLATE ROW COLUMN VECTOR Antibiotic SIZE
1 CG31716 CG31716 RE04975 1 I 4 PFLC1 Amp 3500
2 CHIP CHIP RE01069 1 A 11 PFLC1 Amp 1278
3 l(3)73Ah CG4195 RE11339 1 J 2 PFLC1 Amp 1964
4 ppa CG9952 RE01138 1 A 15 PFLC1 Amp 3449
5 hyd CG9484 RE13070 1 P 8 PFLC1 Amp 9074
6 CG11419 CG11419 RE25242 2 P 20 PFLC1 Amp 1100
7 Trim9 CG31721 RE22018 2 B 14 PFLC1 Amp 3105
8 cdc16 cdc16 RE28575 3 A 24 PFLC1 Amp 2583
9 CG5087 CG5087 RE40614 4 I 1 PFLC1 Amp 3943
10 CG9153 CG9153 RE53774 4 L 6 PFLC1 Amp 3818
11 ARIADNE ari-1 RE69116 5 N 24 PFLC1 Amp 2672
12 CG2617 CG2617 RE60872 5 M 14 PFLC1 Amp 1263
13 Cul-5 CG1401 RE55959 5 G 3 PFLC1 Amp 3511
14 dx CG3929 RE59350 5 G 8 PFLC1 Amp 3824
15 Mes-4 CG4976 RE61305 5 O 8 PFLC1 Amp 4585
16 Roc2 CG8998 RE61847 5 B 5 PFLC1 Amp 590
17 Vhl CG13221 RH61560 9 K 3 PFLC1 Amp 1308
18 lack CG4943 LD16661 10 C 11 pBS-SK- Amp 4865
19 lmg CG18042 AT07979 11 F 13 POTB7 Chlor 2956
20 CG1134 CG1134 AT15655 12 C 20 POTB7 Chlor 1239
21 CG12362 CG12362 AT17761 12 O 2 POTB7 Chlor 1962
22 CG17329 CG17329 AT18988 12 F 23 POTB7 Chlor 673
23 CG5071 CG5071 AT17603 12 M 6 POTB7 Chlor 2241
24 Roc1b  CG16988 AT21612 12 F 2 POTB7 Chlor 514
25 CG4238 CG4238 AT17882 12 O 12 POTB7 Chlor 3515
26 HERC2 CG11734 AT22791 12 L 2 POTB7 Chlor 15796
27 ariadne 2 ari-2 GH07166 13 J 18 POT2 Chlor 3002
28 CG11321 CG11321 GH08772 13 N 6 POT2 Chlor 8769
29 CG13030 CG13030 AT26312 13 I 23 POTB7 Chlor 1448
30 elfless CG15150 AT24563 13 C 1 POTB7 Chlor 1166
31 Cbl Cbl LD46082 14 N 22 POT2 Chlor 3889
32 CG9014 CG9014 LP07794 15 B 15 POT2 Chlor 1359
33 skpF CG12227 LP10147 15 J 11 POT2 Chlor 697
34 CG5604 CG5604 LP05936 15 G 10 POT2 Chlor 8344
35 Roc1a  CG16982 SD23839 16 I 12 POT2 Chlor 1168
36 CG5382 CG5382 GM05688 DGC.1 J 15 pBS SK- amp 1200
37 Cul-3 (guftagu?) CG11861 DGC.1 I 21 pBS SK- amp 2725
38 Gbp CG5519 LD02793 DGC.1 E 21 pBS SK- amp 1774
39 CG4973 CG4973 LD35003 DGC.10 P 22 pOT2 1403
40 d4 CG2682 LD29238 DGC.10 J 9 pOT2 1766
41 Iap2 CG8293 LD34777 DGC.10 P 18 pOT2 2095
42 unk CG4620 LD33756 DGC.10 L 16 pOT2 2710
43 CG10542 CG10542 LD35285 DGC.11 A 21 pOT2 2210
44 CG11982 CG11982 LD47007 DGC.11 F 18 pOT2 1571
45 CG13605 CG13605 LD44641 DGC.11 J 15 pOT2 2122
46 CG17033 CG17033 LD41235 DGC.11 I 14 pOT2 1554
47 CG17260 CG17260 LD44813 DGC.11 L 3 pOT2 1282
48 CG32486 CG32486 LD47625 DGC.11 L 8 pOT2 2347
49 mr (morula) CG3060 LD45730 DGC.11 P 5 pOT2 1451
50 neur (neuralized) CG11988 LD45505 DGC.11 N 19 pOT2 2656
51 shtd (shattered) CG9198 LD37115 DGC.11 I 3 pOT2 1799
52 trx (trithorax) CG8651 LD39445 DGC.11 A 2 pOT2 2552
53 CG11414 CG11414 SD03374 DGC.12 E 8 pOT2 1571
54 CG17019 CG17019 SD05126 DGC.12 K 22 pOT2 2855
55 CG5140 CG5140 GH03577 DGC.12 D 16 pOT2 1539
56 sip3 CG1937 GH11117 DGC.12 L 10 pOT2 2282
57 park (parkin) CG10523 SD01679 DGC.12 M 5 pOT2 1569
58 CG32369 CG32369 GH21463 DGC.13 G 7 pOT2 2452
59 CG4030 CG4030 LD23155 DGC.13 G 20 pOT2 2311
60 CG6752 CG6752 LD30968 DGC.13 D 11 pOT2 2785
61 CG9772 CG9772 GM13370 DGC.13 O 15 pOT2 1975
62 Cul-2 CG1512 LD36177 DGC.13 J 13 pOT2 2817
63 dor CG3093 SD04291 DGC.13 L 6 pOT2 3173
64 CG11261 CG11261 LD29662 DGC.14 G 24 pOT2 2210
65 CG15105 CG15105 GH06739 DGC.14 P 15 pOT2 4683
66 Cul-6 CG11261 LD29662 DGC.14 G 24 pOT2 2210
67 Gol (goliath) CG2679 GH20973 DGC.14 E 15 pOT2 2586
68 msl-2 CG3241 GH22488 DGC.14 N 24 pOT2 3715
69 CG6923 CG6923 LD22771 DGC.15 E 19 pOT2 4531
70 CG9934 CG9934 SD06937 DGC.15 H 12 pOT2 4432
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71 mib1 CG5841 SD05267 DGC.15 D 14 pOT2 4073
72 mib2 CG17492 GH28686 DGC.15 E 5 pOT2 3511
73 POSH CG4909 LD45365 DGC.15 B 23 pOT2 3149
74 CG8184 CG8184 SD03277 DGC.15 P 11 pOT2 3685
75 Nedd4 CG7555 SD04682 DGC.15 B 24 pOT2 3641
76 ARCHIPELAGO ago CG15010 DGC.16 P 2 pOT2 5312
77 CG33144 CG33144 GH08706 DGC.16 A 11 pOT2 4533
78 CG5591 CG5591 GH27953 DGC.16 K 3 pOT2 3354
79 CG9086 CG9086 LD31957 DGC.16 P 12 pOT2 6381
80 Cul-4 CG8711 GM14815 DGC.16 K 19 pOT2 3314
81 rols CG32096 GH15583 DGC.16 J 4 pOT2 5122
82 Topors CG15104 LD43109 DGC.16 E 6 pOT2 4038
83 As CG6190 LD21888 DGC.16 B 17 pOT2 3667
84 CG3356 CG3356 LP03102 DGC.16 G 12 pOT2 3917
85 CG32210 CG32210 SD01201 DGC.17 G 5 pOT2 5405
86 CG10981 CG10981 GM01182 DGC.2 A 3 pBS SK- amp 1660
87 CG15011 CG15011 LD05244 DGC.2 O 11 pBS SK- amp 2903
88 CG32350 CG32350 LD20292 DGC.2 F 4 pBS SK- amp 2870
89 CG7376 CG7376 LD03886 DGC.2 K 23 pBS SK- amp 2250
90 skpA CG16983 HL01263 DGC.2 C 17 pBS SK- amp 1533
91 Trc8 CG2304 LD08152 DGC.2 G 2 pBS SK- amp 1493
92 cdc23 cdc23 LD09850 DGC.3 L 2 pBS SK- amp 2245
93 CG13344 CG13344 GM02568 DGC.3 B 19 pBS SK- amp 1925
94 CG15439 CG15439 LD18949 DGC.3 H 3 pBS SK- amp 2617
95 CG1815 CG1815 LD02460 DGC.3 P 13 pBS SK- amp 2862
96 CG31687 CG31687 LD09850 DGC.3 L 2 pBS SK- amp 2245
97 Cul-1 (lin19) CG1877 LD20253 DGC.3 H 19 pBS SK- amp 2984
98 slmb CG3412 LD08669 DGC.3 H 6 pBS SK- amp 2534
99 CG17735 CG17735 HL01545 DGC.3 D 21 pBS SK- amp 2452
100 Su(dx) CG4244 LD10565 DGC.3 N 24 pBS SK- amp 2901
101 CG16807 CG16807 LD12033 DGC.4 K 10 pBS SK- amp 3332
102 CG2926 CG2926 LD09942 DGC.4 L 15 pBS SK- amp 4435
103 CG2991 CG2991 LD08641 DGC.4 E 4 pBS SK- amp 3147
104 CG9461 CG9461 GM01353 DGC.4 O 16 pBS SK- amp 4150
105 CG11070 CG11070 LD34475 DGC.5 A 24 pOT2 3416
106 CG3231 CG3231 LD21643 DGC.5 E 12 pOT2 3937
107 CG7864 CG7864 GM14467 DGC.5 D 8 pOT2 1048
108 mei-P26 CG12218 GH10646 DGC.5 D 1 pOT2 5254
109 morgue CG15437 GH02435 DGC.5 I 19 pOT2 1698
110 stc CG3647 LD22726 DGC.5 I 8 pOT2 4067
111 CG2681 CG2681 GH02982 DGC.6 E 6 pOT2 1079
112 th (thread) CG12284 GH15335 DGC.6 F 3 pOT2 1484
113 CG7081 CG7081 LD46714 DGC.7 M 7 pOT2 1041
114 poe CG14472 LP02909 DGC.7 A 6 pOT2 1065
115 CG5555 CG5555 GH07062 DGC.8 J 3 pOT2 1976
116 CG8974 CG8974 GH14055 DGC.8 P 22 pOT2 1703
117 Sce CG5595 LD23953 DGC.8 A 14 pOT2 1534
118 sina CG9949 HL08111 DGC.8 C 21 pOT2 2280
119 Traf2 CG10961 GH01161 DGC.8 I 20 pOT2 2785
120 CG15141 CG15141 LD24839 DGC.8 G 12 pOT2 1688
121 CG11534 CG11534 GH12489 DGC.9 M 20 pOT2 1627
122 CG1909 CG1909 GH22690 DGC.9 P 24 pOT2 2405
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Results of the Drosophila DUB RNAi screen 
Of the 29 DUBs screened (out of the 30 predicted in the Drosophila 
genome) (Table 3.2 and Figure 3.3), two “hits” were recovered, both of which 
inhibit Wg signaling when knocked down, indicating they are Wg signaling 
activators.  One of the DUB hits, Cylindromatosis (CYLD, and dsRNA number 11 
in Figure 3.3A), was shown to be a Wnt pathway regulator by the Clevers 
DON'T HAVE bon CG5206
DON'T HAVE CG11360 CG11360
DON'T HAVE CG15800 CG15800
DON'T HAVE CG17048 CG17048
DON'T HAVE CG2709 CG2709
DON'T HAVE CG31053 CG31053
DON'T HAVE CG1392 CG1392
DON'T HAVE CG31807 CG31807
DON'T HAVE CG32581 CG32581
DON'T HAVE CG32847 CG32847
DON'T HAVE CG3639 CG3639
DON'T HAVE CG6613 CG6613
DON'T HAVE CG6688 CG6688
DON'T HAVE CG8419 CG8419
DON'T  HAVE CG9941 CG9941
DON'T HAVE Dnr1 Dnr1
DON'T HAVE hiw (highwire) hiw 
DON'T HAVE ida 
DON'T HAVE lt (light)
DON'T HAVE mat1
DON'T HAVE Mi-2
DON'T HAVE Psc 
DON'T HAVE Su(z)2 
DON'T HAVE CG3099 CG3099
Table 3.1.  List of the predicted E3 ligases in the Drosophila genome used 
for the RNAi screen.   
The numbers in the left-hand column correspond to the numbers of the dsRNAs 
graphed in Figure 3.2.  The corresponding gene names and symbols are 
indicated next to each number in the table. Information regarding the vector in 
which each cDNA is cloned as well as where each clone is located in the 
Drosophila Gene Collection (DGC) 1 and 2 is shown at right.  The clones that 
are not found in the DGC, and thus were not screened, are noted at the end of 
the table.      
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laboratory (Wnt Meeting, Berlin) at the time I performed this screen, further 
validating my approach for identifying bona fide Wg/Wnt regulators in my DUB 
RNAi screen.  They have now published a paper indicating CYLD cleaves K63-
linked polyubiquitin chains from Dsh, which inhibits Wnt signaling, as described in 
Chapter I (Tauriello et al., 2010).  Thus, again, my results were opposite of those 
found in human cells as my data gathered in S2 cells indicated that CYLD is a 
positive Wg signaling regulator.  Regardless of this discrepancy, my screen 
identified CYLD as a potential Wnt pathway regulator indicating I was able to 
identify novel Wnt pathway components using this method.     
Because CYLD was already under investigation by another laboratory, I 
decided to focus on the other DUB hit, Ubiquitin Binding Protein 64 E (Ubp64E, 
and dsRNA number 15 in Figure 3.3A), whose human homolog is Ubiquitin 
Specific Peptidase 47 (USP47), a putative DUB that had no known function at the 
time I began my studies.  Characterization of this DUB hit is described in Chapter 
V.   
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Figure 3.3.  Results of Drosophila DUB RNAi screen for Wg/Wnt 
signaling regulators.   
(A and B)  Results of TOPflash activity normalized to β-galactosidase 
activity relative to –Wg treatment.  Mean ± standard deviation (SD) of each 
dsRNA treatment performed in triplicate is shown. Arm serves as a control 
for positive regulators of Wg/Wnt signaling.  Asterisk indicates the “hit” I 
chose to pursue and is described in Chapter V. 
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Discussion 
Performing a targeted RNAi screen in Drosophila S2 cells provided two 
advantages over performing an RNAi screen in mammalian cells or over 
previously reported Wnt pathway RNAi screens:  1) there is less redundancy in 
DUB Collection # SYMBOL Clone ID Predicted Gene  Plate  Row Column Vector Antibiotic Size cDNA Accession
1 CG8494 HL02756 3 E 18 pBS SK- amp 1990 AY069300
2 isopep-T-3 LD10242 CG11025 3 L 24 pBS SK- amp 2404 BT004899
3 CG7023 RE52890 4 H 2 PFLC1 Amp
4 CG15817 LD22910 5 I 10 pOT2 4860 AF181650
5 CYLD RE64280 CG5603 5 N 1 PFLC1 Amp
6 faf LD22582 CG1945 5 I 4 pOT2 5393 AF145677
7 Uch GH02396 CG4265 5 I 13 pOT2 1068 AF145600
8 Uch-L3 LD24440 CG3431 5 E 9 pOT2 1153 AF132567
9 Ulp1 GH02751 CG12359 5 K 9 pOT2 3449 AF145608
10 CG12082 RE70722 6 E 13 PFLC1 Amp
11 dp SD02173 CG33196 7 G 24 pOT2 1245 AY122242
12 CG8445 GH01941 8 O 12 pOT2 2148 AY047515
13 CG1950 AT10439 11 D 20 POTB7 Chlor
14 not LD43147 CG4166 11 B 19 pOT2 2508 AY058707
15 Ubp64E LD38333 CG5486 11 M 7 pOT2 3143 AY058672
16 CG3016 LD41827 13 N 17 pOT2 2314 AY069649
17 CG5384 LD40495 13 L 23 pOT2 1715
18 CG5794 AT30546 13 D 15 POTB7 Chlor
19 CG7288 LD38070 13 L 7 pOT2 1700 AY061442
20 Usp7 LD41613 CG1490 13 N 15 pOT2 2224 AY061459
21 CG8232 LD22095 14 B 19 pOT2 AY119601
22 CG14619 SD04280 15 B 10 pOT2 3450 AY069803
23 CG4165 LD34905 15 G 2 pOT2 4221 AY051846
24 CG5798 SD04548 15 B 16 pOT2 3208 AY122247
25 mule LD40339 CG5505 15 K 18 pOT2 3515 AY051916
26 CG30421 GH27809 16 L 8 pOT2 5184 AY060809
27 CG32479 LD28815 16 N 6 pOT2 6352 AY122170
28 CG8334 SD15907 16 E 23 POT2 Chlor
29 CG8830 LD36231 16 C 14 pOT2 3195
30 ec CG2904
Table 3.2.  List of the predicted DUBs in the Drosophila genome used for 
the RNAi screen.   
The numbers in the left-hand column correspond to the numbers of the 
dsRNAs graphed in Figure 2.3.  The corresponding gene names and symbols 
are indicated next to each number in the table. Information regarding the 
vector in which each cdna is cloned as well as where each clone is located in 
the Drosophila Gene Collection 1 and 2 is shown at right.    
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gene function in S2 cells than in mammalian cells, making it easier to identify 
genes that affect Wg/Wnt signaling, and 2) focusing solely on E3s and DUBs 
instead of the entire genome (as was done by (DasGupta et al., 2005)), reduced 
the amount of error that comes with handling a large number of samples as well 
as simplified the data analysis once the screen was completed.  Additionally, the 
smaller number of samples allowed re-testing of the most promising hits in a time-
efficient manner.   
While no screen is perfect and false negatives and false positives are 
always identified, I deem a screen successful if it uncovers any novel biology.  To 
this end, both the E3 and DUB RNAi screens I performed as described here were 
successful.  The E3 ligase screen allowed me to identify DIAP1, whose human 
homolog is XIAP, as a novel key Wg/Wnt signaling regulator.  My E3 screen did 
not identify the key Wg/Wnt signaling regulator Slimb/β-TRCP, indicating there 
are false negatives in my data set, but it did pick up Trithorax/MLL as a Wg/Wnt 
signaling component, which has now been shown to be a Wnt pathway regulator.  
Thus, I was able to identify a bona fide Wnt pathway regulator in my E3 RNAi 
screen.   
Similarly, I identified the DUB Ubp46E, whose human homolog is USP47, 
as a novel Wg/Wnt pathway regulator in my DUB RNAi screen.  I did not identify 
the other DUBs that have now been shown to be Wnt pathway regulators, as 
discussed in Chapter I, indicating there are also false negatives in my DUB data 
set.  However, I did identify CYLD as a Wg/Wnt pathway regulator, which has now 
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been shown to be a bona fide Wnt pathway component indicating I was able to 
identify novel DUBs involved in regulating Wnt signaling.           
While these screens identified other E3s and DUBs that remain to be 
characterized, I chose to focus on one E3 and one DUB for my thesis work.  I will 
discuss the E3 ligase screen hit, XIAP, in detail in Chapter IV and the DUB screen 
hit, USP47, in Chapter V.  
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CHAPTER IV 
 
XIAP MONO-UBIQUITYLATES GROUCHO/TLE TO PROMOTE CANONICAL 
WNT SIGNALING 
 
Introduction 
The canonical Wnt signaling pathway is present in all metazoans and 
regulates many developmental processes (Logan and Nusse, 2004; MacDonald 
et al., 2009). Misregulation of the Wnt pathway results in a variety of disease 
states in humans, including cancer. β-catenin is the main cytoplasmic effector in 
the Wnt pathway. In the absence of Wnt ligand, a β-catenin destruction complex, 
composed of Axin, glycogen synthase kinase 3 (GSK3), casein kinase I α (CKIα), 
and the tumor suppressor adenomatous polyposis coli (APC), promotes 
phosphorylation of β-catenin, targeting it for ubiquitin-mediated proteasomal 
degradation. Binding of a Wnt ligand to its two cell-surface receptors, Frizzled (Fz) 
and LDL receptor-related protein 5/6 (LRP5/6), results in inhibition of β-catenin 
phosophorylation and, thus, stabillzation of β-catenin. Stabilized β-catenin 
translocates to the nucleus where it binds to TCF/Lef to activate a Wnt-specific 
transcriptional program. 
A critical nuclear event that occurs upon Wnt pathway activation is the β-
catenin-mediated conversion of TCF/Lef from a transcriptional repressor to a 
transcriptional activator. In the absence of a Wnt signal, TCF/Lef is bound to the 
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Groucho (Gro)/TLE family of transcriptional co-repressors to repress transcription 
of Wnt target genes (Cavallo et al., 1998; Roose et al., 1998). This transcriptional 
repression is thought to involve recruitment of histone deacetylases by Gro/TLE 
to alter local chromatin structure as well as a role for Gro/TLE oligomerization, 
which promotes long-range chromosome condensation (Buscarlet and Stifani, 
2007; Jennings and Ish-Horowicz, 2008). According to the current model of Wnt 
signaling, a pool of β-catenin that enters the nucleus upon Wnt pathway 
activation directly competes with Gro/TLE for TCF/Lef binding (Daniels and Weis, 
2005). Once bound to TCF/Lef on chromatin, β-catenin recruits a co-activator 
complex, thereby converting TCF/Lef into a transcriptional activator. 
The Wnt pathway contains many components that are known to be 
regulated by ubiquitylation (Tauriello and Maurice, 2010). E3 ubiquitin ligases for 
β-catenin (Jiang and Struhl, 1998; Marikawa and Elinson, 1998) and Dishevelled 
(Angers et al., 2006) have been reported, but little was known about other E3 
ligases that regulate Wnt signaling at the time we began our study. Thus, we 
sought to identify novel E3 ligases involved in Wnt signaling to gain a better 
understanding of how the ubiquitin system regulates this pathway. 
Here, we performed a targeted RNAi screen in Drosophila S2 cells to 
identify novel E3 ubiquitin ligases involved in Wingless (Wg, the Drosophila 
homolog of Wnt) signal transduction that led to our identification of Drosophila 
Inhibitor of Apoptosis 1 (DIAP1) as a critical Wg pathway component. We 
demonstrate that the human homolog, X-linked Inhibitor of Apoptosis (XIAP), is 
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similarly required for Wnt signaling in cultured human cells and Xenopus 
embryos, indicating evolutionary conservation of function. In response to Wnt 
pathway activation, we show that XIAP is recruited to TCF/Lef transcriptional 
complexes where it binds and ubiquitylates Gro/TLE, thereby decreasing the 
affinity of Gro/TLE for TCF/Lef. Together, our data reveal a mechanism by which 
ubiquitin-mediated removal of Gro/TLE from TCF/Lef bound to chromatin is 
required in order to allow assembly of β-catenin-TCF/Lef complexes that can 
initiate a Wnt-specific transcriptional program. In contrast to a direct 
displacement model in which β-catenin and Gro/TLE simply compete for TCF/Lef 
binding (Daniels and Weis, 2005), we provide evidence for a more intricate 
transcriptional switch in the Wnt pathway. This Wnt signaling circuitry, involving 
the coincident activities of β-catenin and XIAP, may explain why modest changes 
in β-catenin levels in response to Wnt ligand are sufficient to robustly activate the 
pathway.  
 
Results 
 
Drosophila RNAi screen identifies DIAP1 as a critical component of the 
Wingless signaling pathway 
To identify novel E3 ubiquitin ligases involved in Wingless (Wg) signaling, 
we performed a genome-scale RNAi-based screen targeting E3 ubiquitin ligases 
in Drosophila S2 cells (Figure 4.1A, see Chapter II for details). Plasmids 
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encoding experimentally verified and predicted E3 ubiquitin ligases (122 clones 
total) were obtained from the Drosophila Gene Collection Release 1 and 2, and a 
PCR approach was used to generate linear cDNA products suitable for in vitro 
dsRNA synthesis. For the screen, dsRNA was added to a Drosophila S2R+ 
reporter cell line stably transfected with the Wg responsive TOPflash luciferase 
reporter (Korinek et al., 1997).   
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Figure 4.1.  Drosophila S2 cell RNAi screen identifies the E3 ligase 
DIAP1 as a positive regulator of Wingless signaling.  
(A) Schematic of RNAi screen to identify E3 ubiquitin ligases that regulate 
Wingless signaling in Drosophila S2 cells (see text for more details).  
(B) Results of RNAi screen. Graph represents mean ± standard deviation 
(SD) of TOPflash normalized to cell number. Axin and Armadillo (Arm) 
dsRNA treatments were performed as controls. Results for DIAP1 dsRNA 
(112) and 12 additional dsRNAs included in the screen are shown. Results 
are representative of at least three experiments performed in quadruplicate. 
*p-value < 0.01, **p-value < 0.001 versus +Wg.  
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Axin (a potent negative regulator of Wg signaling) and Armadillo (Arm, the 
Drosophila β-catenin homolog and potent positive regulator of Wg signaling) 
served as controls to confirm effective knockdown by dsRNA treatment in our 
screen (Figure 4.1B). Of the 122 E3 ubiquitin ligases screened, the knockdown of 
one (no. 112) was particularly potent in inhibiting Wg signaling, reducing 
TOPflash activity to a similar extent as knocking down Arm. dsRNA no. 112 
targets Drosophila Inhibitor of Apoptosis 1 (DIAP1), a well-characterized anti-
apoptotic effector and a member of the evolutionarily conserved Inhibitor of 
Apoptosis protein (IAP) family (Srinivasula and Ashwell, 2008). We chose to 
pursue this hit further because it suggested an unexpected link between a classic 
IAP family member and regulation of the Wg signaling pathway. 
 
XIAP is required for Wnt signaling in cultured mammalian cells 
We next sought to determine if XIAP, the homolog of DIAP1, is similarly 
required for Wnt signaling in mammalian cells. We tested the effects of XIAP 
knockdown on Wnt3a-induced transcriptional activation using a human 
embryonic kidney (HEK) 293 cell line stably transfected with the TOPflash 
reporter (STF293) (Xu et al., 2004). Knockdown of XIAP with two independent 
short-interfering RNA (siRNA) constructs significantly blocked Wnt3a-induced 
TOPflash activation (Figure 4.2A), while having no observable effect on the 
activity of a constitutively active luciferase reporter (CMV-Luciferase) (Thorne et 
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al., 2010) or a Notch reporter (Minoguchi et al., 1997) (Figure 4.3), indicating 
specific  
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Figure 4.2. XIAP is required for Wnt signaling in cultured mammalian cells.  
(A and B) Knockdown of XIAP by siRNA inhibits Wnt signaling. (A) HEK293 STF 
(STF293) cells were transfected with non-targeting control (Con) or two 
independent XIAP siRNAs and treated with L cell (L-CM) or Wnt3a cell- (Wnt3a-
CM) conditioned media for 24 hrs. Graph shows mean ± SD of TOPflash 
normalized to cell number. Immunoblotting confirmed knockdown of XIAP 
protein and Wnt3a-mediated stabilization of β-catenin. GAPDH is loading 
control. *p-value < 0.0001 versus Wnt3a-CM-treated Con. (B) Quantitative real-
time RT-PCR of endogenous Wnt target gene, AXIN2, in HEK293 cells treated 
with XIAP siRNAs or non-targeting control. Graph is ratio of AXIN2 to PMMD1 
mRNA (control). Results (mean ± SD) of four independent real-time RT-PCR 
reactions are shown. *p-value < 0.0005 versus Wnt3a-CM-treated Con. 
(C and D) XIAP is required downstream of β-catenin stabilization for Wnt 
signaling in multiple cell types. (C) STF293 cells were transfected with XIAP 
siRNAs or non-targeting control and treated with 30 mM LiCl. Graph shows 
mean ± SD of TOPflash normalized to cell number. Immunoblots confirmed 
knockdown of XIAP protein and LiCl-mediated stabilization of β-catenin. GAPDH 
is loading control. *p-value < 0.0001 versus LiCl-treated Con. (D) Knockdown of 
XIAP inhibits Wnt signaling in the colon cancer lines SW480 and HCT116. 
SW480 cells were transfected with TOPflash and XIAP siRNAs or non-targeting 
control. XIAP-deficient HCT116 cells (XIAP KO) were transfected with 
TOPflash. Graphs show mean ± SD of TOPflash normalized to Renilla 
luciferase (transfection control). Immunoblots confirmed loss of XIAP protein. No 
observable change in β-catenin levels was detected. GAPDH is loading control. 
*p-value < 0.0005, **p-value < 0.0001 versus Con or XIAP WT. 
(E) Overexpression (OE) of XIAP does not increase TOPflash activity. STF293 
cells were transfected with XIAP and treated with L-CM or Wnt3a-CM for 24 hrs. 
Graph shows mean ± SD of TOPflash activity normalized to cell number. 
Immunobloting confirmed increased XIAP expression and Wnt3a-induced β-
catenin stabilization. GAPDH is loading control. All TOPflash results are 
representative of at least three independent experiments performed in triplicate.  
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Figure 4.3. Knockdown of XIAP does not inhibit CMV-Luciferase or Notch 
signaling.  
(A) HEK293 cells stably transfected with CMV-Luciferase (CMV-Luc) were 
transfected with non-targeting control (Con) or two independent XIAP siRNAs. 
Graph shows mean ± SD of CMV-luc normalized to cell number. Immunoblot 
confirmed knockdown of XIAP protein by XIAP siRNA but not control siRNA. 
GAPDH is loading control. Results represent at least three independent 
experiments performed in triplicate.  
(B) To assess the effect of XIAP knockdown on Notch signaling, HEK293 cells 
were transfected with TP1-Luc (Notch reporter) and Notch intracellular domain 
(ICV) plus either non-targeting control (Con) or two independent XIAP siRNAs. 
Graph shows mean ± SD of reporter firefly luciferase activity normalized to 
Renilla luciferase (transfection control). Immunoblotting confirmed knockdown 
of XIAP. GAPDH is loading control. Results represent at least three 
independent experiments performed in triplicate.  
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inhibition of TOPflash activity. XIAP knockdown also inhibited Wnt3a-induced 
expression of endogenous AXIN2 transcripts, further indicating that XIAP is 
required for Wnt-mediated transcriptional activation (Figure 4.2B). 
Figure 4.4. XIAP loss or knockdown has no effect on β-catenin levels 
or localization.  
(A) A HCT116 cell line in which XIAP has been stably knocked out 
(HCT116 XIAP KO) and a corresponding wild-type control (HCT116 XIAP 
WT) were fixed, and immunostained for β-catenin. No change in β-catenin 
levels or localization were observed (greater than 300 cells scored per 
condition). Scale bars, 5 µm.  
(B) HeLa cells were transfected with control (Con) or XIAP siRNA, treated 
with LiCl as indicated, and stained for β-catenin and DNA. 20.8% (33/158) 
of control-siRNA and 20.6% (32/155) of XIAP-siRNA cells treated with LiCl 
were positive for nuclear β-catenin. Scale bars, 5 µm. 
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Knockdown of XIAP did not change the levels of cytoplasmic β-catenin, 
suggesting that XIAP is functioning downstream of the β-catenin destruction 
complex (Figure 4.2A and 4.4). To further test this possibility, we investigated 
whether knockdown of XIAP could inhibit Wnt signaling in cells treated with 
lithium (which inhibits the destruction complex kinase GSK3). We found that 
knockdown of XIAP inhibited TOPflash activation in STF293 cells even when the 
β-catenin destruction complex is inhibited by lithium and elevated levels of β-
catenin are present (Figure 4.2C).  
The SW480 and HCT116 colon cancer cell lines have significantly 
decreased capacity to degrade β-catenin due to mutations in APC and β-catenin, 
respectively (Korinek et al., 1997; Morin et al., 1997). Both cell lines exhibit 
constitutively active, ligand-independent Wnt signaling. Knockdown of XIAP by 
RNAi inhibited Wnt signaling in SW480 cells but had no observable effect on β-
catenin protein levels (Figure 4.2D). Wnt signaling was also significantly reduced 
without reduction in β-catenin levels in HCT116 cells deficient for XIAP (generous 
gift from B. Vogelstein, Johns Hopkins University). Furthermore, we did not 
detect any change in the localization of β-catenin in the absence of XIAP (Figure 
4.4A) or when XIAP was knocked down by RNAi (Figure 4.4B).  
In contrast to downregulation of XIAP, overexpression of XIAP had no 
observable effect on Wnt pathway signaling in the absence or presence of Wnt 
ligand, suggesting that XIAP is not a limiting Wnt pathway component in the cell 
lines we tested (Figure 4.2E). Together, these data indicate that XIAP is required 
 67 
for activation of Wnt target genes in cultured mammalian cells and that it likely 
functions downstream of β-catenin stabilization.  
 
XIAP is required for Wnt signaling in Xenopus embryos 
To determine if XIAP is required for Wnt signaling in a developing 
organism, we investigated its role in dorsal-anterior structure formation in 
Xenopus laevis embryos; a process that is critically regulated by Wnt signaling 
(Heasman, 2006). Consistent with Wnt pathway inhibition, knockdown of XIAP by 
dorsal injection of two independent XIAP morpholinos inhibited dorsal-anterior 
structure formation and resulted in severely ventralized embryos (Figure 4.5A). 
To more specifically examine whether the ventralized phenotype we 
observed was due to Wnt pathway inhibition, we tested the effect of XIAP 
knockdown on Xwnt8-induced secondary axes. There was a significant reduction 
in the number of secondary axes when Xwnt8 mRNA was co-injected ventrally 
with XIAP morpholino versus control morpholino (Figure 4.5B). Additionally, co-
injection of XIAP morpholino with Xwnt8 mRNA into Xenopus animal caps 
significantly reduced expression of the Xwnt8 target genes Xnr3 and Siamois, 
further demonstrating a requirement for XIAP for Wnt signaling in Xenopus 
embryos (Figure 4.5C).  
Ventral injection of XIAP mRNA induced partial secondary axes, 
consistent with Wnt pathway activation (McMahon and Moon, 1989). In contrast 
to the cultured mammalian cell results where overexpression of XIAP did not 
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observably affect Wnt signaling, overexpression of XIAP in Xenopus embryos 
was sufficient to ectopically activate the Wnt pathway (Figure 4.5D). Together, 
these results show that XIAP is required for Wnt signaling and dorsal axis 
formation during Xenopus development.  
 69 
 
Figure 4.5. XIAP is required for Wnt signaling in vivo.  
(A) XIAP is required in Xenopus embryos for dorsal-anterior patterning. Embryos 
(4-cell stage) were injected dorsally with control (Con MO) or two independent 
XIAP morpholinos (XIAP MO#1 and #2) (25 ng) and dorsal-anterior index (DAI) 
determined (Kao and Elinson, 1988). The percentage of ventralized embryos 
(DAI <= 2) is graphed on the left (absolute numbers above bars) with 
representative embryos on the right. *p-value < 0.0001 versus Con MO. 
(B) Downregulating XIAP by morpholino injection inhibits Xwnt8-induced 
secondary axis formation. Embryos (4-cell stage) were co-injected ventrally with 
Xwnt8 mRNA (0.7 pg) plus control or XIAP morpholino (25 ng). The percentage 
of embryos with secondary axis formation is graphed on the left (absolute 
numbers above bars) with representative embryos on the right. *p-value < 0.0001 
versus Xwnt8/Con MO.  
(C) XIAP is required for Xwnt8-induced expression of Wnt target genes in 
Xenopus ectodermal explants. Total RNA was extracted from animal caps co-
injected with Xwnt8 mRNA (0.7 pg) and control or XIAP morpholino (25 ng) and 
Siamois and Xnr3 gene expression assayed by RT-PCR. WE = whole embryo 
control. RT = reverse transcriptase. Ornithine decarboxylase (ODC) is loading 
control.  
(D) XIAP induces secondary axis formation. Embryos (4-cell stage) were injected 
ventrally with control (Con) or XIAP mRNA (2 ng) and allowed to develop. The 
percentage of embryos with secondary axis formation is graphed on the left 
(absolute numbers above bars) with representative embryos on the right. *p-
value < 0.0001 versus Con. 
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XIAP binds and ubiquitylates Groucho/TLE 
 Having demonstrated that XIAP is required for Wnt signaling across phyla, 
our next aim was to elucidate the molecular mechanism of its function in the Wnt 
pathway. Based on our cultured mammalian cell studies, it is likely that XIAP acts 
in the Wnt pathway downstream of the destruction complex. Thus, we took a 
candidate approach and performed co-immunoprecipitation experiments with 
tagged XIAP and tagged versions of a majority of the known nuclear Wnt 
pathway components. Of all of the proteins screened, only the transcriptional co-
repressor Transducin-like enhancer of split 3 (TLE3, the mammalian homolog of 
Drosophila Groucho) co-immunoprecipitated with XIAP (Figure 4.6A and data not 
shown). The interaction between XIAP and TLE3 was confirmed by 
demonstrating that endogenous XIAP co-immunoprecipitated with endogenous 
TLE3 in the absence and presence of Wnt stimulation (Figure 4.6B).  
These results prompted us to ask where XIAP and TLE3 interact in the 
cell.  XIAP is thought to be primarily a cytoplasmic protein, although it can be 
translocated to the nucleus under certain conditions (Liston et al., 2001; Russell 
et al., 2008), while TLE3 is found almost exclusively in the nucleus. We analyzed 
the subcellular localization of XIAP and TLE3 in the absence and presence of 
Wnt signaling and detected no observable changes in the localization of either 
protein upon Wnt stimulation (Figure 4.7A and data not shown). Notably, 
although the majority of XIAP is found in the cytoplasm, there is an observable 
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nuclear pool of endogenous XIAP (in the presence and absence of Wnt 
stimulation), which can be dramatically enhanced by overexpression of TLE3 
(Figure 4.7B), indicating these two proteins can co-localize in the nucleus and 
that TLE3 levels can alter the population of XIAP in the nucleus. 
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Figure 4.6. XIAP binds and ubiquitylates Groucho/TLE. 
(A and B) XIAP interacts with Groucho/TLE3. (A) Tagged XIAP co-
immunoprecipitates with tagged Groucho/TLE. HEK293 cells were 
transfected as indicated with Flag-XIAP and HA-TLE3 and treated with 
Wnt3a-CM. Cells were lysed and XIAP immunoprecipitated with anti-Flag 
antibody. Co-immunoprecipitated TLE3 was detected by anti-HA antibody. 
(B) Endogenous XIAP co-immunoprecipitates with endogenous TLE3. 
HEK293 cells were treated with L-CM or Wnt3a-CM for 3 hrs, lysed, and 
immunoprecipitated with anti-XIAP antibody. Co-immunoprecipitated 
proteins were detected by immunoblotting.  
(C, D, and E) His-ubiquitylation assays.  HEK293 cells were transfected as 
indicated, lysed under denaturing conditions, and His-Ub modified proteins 
isolated by nickel affinity purification. XIAP and TLE were detected by 
immunoblotting with anti-myc and anti-Flag antibodies, respectively. WCL = 
whole cell lysates. IB = immunoblot. (C) XIAP ubiquitylates Groucho/TLE3 in 
cultured mammalian cells. (D) XIAP ubiquitylates Groucho/TLE independent 
of its anti-apoptotic function. Flag-XIAP casp-mut is a mutant form of XIAP 
that cannot bind and inhibit caspases. (E) Knockdown of XIAP inhibits 
Groucho/TLE ubiquitylation.  
(F) XIAP ubiquitylates Groucho/TLE in vitro. In vitro-translated myc-TLE3 
was incubated in an in vitro ubiquitylation assay with recombinant proteins 
as indicated and visualized by immunoblotting with anti-myc antibody. Ub 
KO is a mutant form of ubiquitin in which all seven lysines have been 
mutated to arginines, allowing only for mono-ubiquitylation of substrates. 
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Figure 4.7. TLE3 promotes XIAP nuclear localization. 
(A) Wnt stimulation does not alter nuclear localization of XIAP. HEK293 cells 
were treated with L-CM or Wnt3a-CM, fixed, and immunostained for XIAP.  
For each condition, greater than 300 cells were assessed. No change in XIAP 
staining was detected for any cells. Scale bars, 5 µm. 
 (B) TLE3 promotes nuclear localization of XIAP. HEK293 cells were 
transfected with myc or myc-TLE3 as indicated and stained for endogenous 
XIAP and myc. Greater than 300 cells were scored for each condition. All cells 
expressing myc-TLE3 showed enhanced XIAP nuclear staining. In contrast, no 
enhanced nuclear XIAP staining was detected in the myc control cells. Scale 
bars, 5 µm. 
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Figure 4.8.  Domain Structure of the IAP Protein Family. 
The characteristic BIR domains are indicated by red rectangles, CARD 
domains by purple rectangles, RING domains by green ovals, NBD 
domains by diamonds, LRR domains by teal circles, and UBC domains 
(conserved domains found in E2 ubiquitin-conjugating enzymes) by 
yellow hexagons. Diap1, Diap2, Deterin, and dBruce are Drosophila 
IAPs, while SfIAP1 and TnIAP are lepidopteran IAPs. IAP, inhibitor of 
apoptosis; XIAP, X-linked IAP; BIRC, baculoviral IAP repeat containing; 
hILP, human IAP-like protein; Ts-IAP, testis-specific IAP; c-IAP, cellular 
IAP; ML-IAP, melanoma-IAP; NAIP, neuronal apoptosis inhibitory protein; 
DIAP, Drosophila IAP; SfIAP1, Spodoptera frugiperda IAP; TnIAP, 
Trichoplusia ni IAP; CeBIR-1,-2, Caenorhabditis elegans BIRC; SpIAP, 
Schizosaccharomyces pombe IAP; ScIAP, Saccharomyces cerevisiae 
IAP; BIR, baculoviral IAP repeat; CARD, caspase recruitment domain; 
NBD, nucleotide binding oligomerization domain; LRR, leucine rich 
repeat.  Figure from (O’Riordan et al., 2008).   
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XIAP is a member of the highly conserved Inhibitor of Apoptosis (IAP) 
protein family (Figure 4.8).  The IAP family was originally named after the 
discovery of the first family member, which was shown to be an inhibitor of 
apoptosis in baculovirus in 1994 (O'Riordan et al., 2008).  For many years the 
IAP proteins have thus been studied primarily in terms of their anti-apoptotic 
functions, but it is becoming clear that IAPs have diverse roles in the cell in 
addition to inhibiting apoptosis (Galban and Duckett, 2010; O'Riordan et al., 
2008; Srinivasula and Ashwell, 2008).  Members of the IAP protein family contain 
two classic structural features:  the baculovirus IAP repeat (BIR) and the Really 
Interesing New Gene (RING) domain.  The BIR domain is the defining feature of 
IAP family members, with IAPs containing between one and three BIRs (Figure 
4.8).  It was originally thought that the BIR domains function to inhibit cell death 
by directly binding and inhibiting caspases, but it is now known that XIAP is the 
only family member that inhibits apoptosis through direct binding and inhibition of 
effector caspases 3, 7, and 9.  The other IAP family members, of which there are 
seven in humans, are thought to bind caspases via their BIR domains, but are 
unable to directly inhibit caspase enzymatic activity (O'Riordan et al., 2008; 
Srinivasula and Ashwell, 2008).    
In addition to the classic BIR domain, many IAPs contain a C-terminal 
RING domain.  For many years the RING domain of IAPs was ignored because 
the function of RING domains was not known.  Thus, most work tended to focus 
on the anti-apoptotic effects of IAPs via their BIR domains.  It has since been 
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discovered that RING domains confer E3 ligase activity to their cognate proteins 
and, consequently, a variety of apoptotic and non-apoptotic functions for the 
RING domains of IAPs have now been uncovered (O'Riordan et al., 2008; 
Srinivasula and Ashwell, 2008).  The most well characterized RING-containing 
human IAP is XIAP, which contains three BIR domains and a C-terminal RING 
domain (Figure 4.8) (O'Riordan et al., 2008).  For years XIAP was studied 
primarily as an inhibitor of apoptosis via its BIR domains, but has now been 
shown to be involved in diverse cellular processes, many of which require its 
RING domain (Galban and Duckett, 2010).  The RING domain of XIAP is even 
thought to be required for its anti-apoptotic activity via ubiquitylation and 
degradation of pro-apoptotic factors such as the XIAP inhibitor second 
mitochondria-derived activator of caspase (Smac) (MacFarlane et al., 2002).  
Additionally, it has been proposed that XIAP may ubiquitylate caspases, which 
does not lead to their proteasomal degradation, but rather, inhibits their 
enzymatic activity (Ditzel et al., 2008).  Aside from these apoptotic functions, 
roles for XIAP and its RING domain have been identified in NF-κB and TGFβ 
signaling, innate immunity, cell division, and copper homeostasis (Galban and 
Duckett, 2010).  Aside from Copper metabolism (Murr1) domain containing 1 
(COMMD1), which is ubiquitylated by XIAP and subsequently degraded (Burstein 
et al., 2004), no other true “targets” for XIAP-mediated ubiquitylation in these 
non-apoptotic roles have been discovered.  
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Given the emerging role of XIAP and its RING domain in non-apoptotic 
functions, we sought to determine if XIAP is functioning as an E3 ligase for 
Gro/TLE in the Wnt pathway via its RING domain using a previously described 
assay (Salghetti et al., 1999). Cells were transfected with myc-TLE3, His-
Ubiquitin, and either Flag-XIAP or Flag-XIAP-ΔRING. His-ubiquitylated proteins 
were isolated under denaturing conditions by nickel affinity purification, and myc-
TLE3 was detected by immunoblotting. In the absence of XIAP, a band 
corresponding to the mono-ubiquitylated species of TLE3 was detected that is 
significantly enhanced when full-length XIAP, but not XIAP-ΔRING, was 
overexpressed, indicating the RING domain of XIAP is required for the enhanced 
ubiquitylation of TLE3 by XIAP (Figure 4.6C). Higher molecular weight species of 
TLE3 were also present in the whole cell lysate in the presence of full-length 
XIAP, but not XIAP-ΔRING, further supporting the His-Ubiquitin pull-down results.  
To investigate whether the anti-apoptotic activity of XIAP is required for 
ubiquitylation of TLE3, we overexpressed a previously characterized form of 
XIAP with point mutations in each of its three BIR domains that abolish its 
capacity to bind and inactivate caspases (Lewis et al., 2004). Overexpression of 
this mutant form of XIAP enhanced the ubiquitylation of TLE3 to a similar extent 
as wild-type XIAP, indicating that the anti-apoptotic functions of XIAP are not 
required for its capacity to ubiquitylate TLE3 (Figure 4.6D). Overexpression of 
Second mitochondria-derived activator of caspases (Smac), a small peptide that 
binds to the BIR2 and BIR3 domains of XIAP and inhibits its anti-apoptotic 
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activity (Huang et al., 2003), similarly had no effect on the capacity of XIAP to 
ubiquitylate TLE3 (Figure 4.9). Based on these results, we conclude that the 
capacity of XIAP to enhance TLE3 ubiquitylation requires its C-terminal RING 
domain but is independent of its anti-apoptotic functions.  
 
 
XIAP has two closely related homologs, cellular Inhibitor of Apoptosis 1 
and 2 (cIAP1 and cIAP2) (Figure 4.8). In some cases cIAP1 and cIAP2 have 
redundant activity with XIAP and have been shown to be capable of 
compensating for loss of XIAP (Srinivasula 2008). To determine if c-IAP1 or c-
IAP2 are also capable of ubiquitylating TLE3, we performed an ubiquitylation 
assay in cells using tagged versions of both proteins. We found that, in contrast 
Figure 4.9. Overexpression of Smac does not inhibit XIAP-mediated 
Groucho/TLE ubiquitylation.  
HEK293 cells were transfected as indicated and His-ubiquitylated 
proteins were isolated by nickel affinity purification.   
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to XIAP, neither c-IAP1 or c-IAP2 have the capacity to promote the ubiquitylation 
of TLE3 (Figure 4.10). This finding suggests that ubiquitylation of TLE3 is not a 
general property of IAP family members, but is specific to XIAP. 
 
 
 
 
 
 
Figure 4.10. Overexpression of cIAP1 or cIAP2 fails to promote 
Groucho/TLE3 ubiquitylation. 
HEK293 cells were transfected as indicated, lysed under denaturing 
conditions, and His-Ub modified proteins isolated by nickel affinity 
purification.  TLE3 was detected by immunoblotting with anti-HA 
antibodies. XIAP, cIAP1, and cIAP2 were detected by immunoblotting 
with anti-Flag and anti-myc antibodies, respectively. 
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To investigate whether endogenous XIAP is required for TLE3 
ubiquitylation, we knocked down XIAP in HEK293 cells using siRNA and 
performed an ubiquitylation assay using His-Ubiquitin and myc-TLE3 as 
described above. Our results show that the ubiquitylation of TLE3 is significantly 
decreased when XIAP is knocked down, indicating that endogenous XIAP is 
likely required for ubiquitylation of TLE3 in cells (Figure 4.6E).    
To more directly determine if XIAP can bind and ubiquitylate TLE3, we 
performed an in vitro ubiquitylation assay using recombinant XIAP (Figure 4.6F). 
We find that recombinant XIAP, but not XIAP-ΔRING, is capable of ubiquitylating 
TLE3 in vitro.  The addition of wild-type ubiquitin and KO ubiquitin (ubiquitin in 
which all lysines have been mutated to arginine, making this mutant incapable of 
forming polyubiquitin chains) resulted in identical patterns of ubiquitylated TLE3 
species as detected by immunoblotting. In contrast, ubiquitylated TLE3 species 
were not detected in the absence of added ubiquitin. The XIAP-mediated in vitro 
ubiquitylation pattern of TLE3 is essentially identical to the ubiquitylation pattern 
of TLE3 we observed when XIAP is overexpressed in cultured cells (Figure 
4.6C). These results suggest that XIAP has the capacity to directly ubiquitylate 
TLE3 via its RING domain and that it likely conjugates multiple monoubiquitin 
moieties onto TLE3 (a prominent single mono-ubiquitin moiety as well as a less-
abundant second mono-ubiquitin moiety).  
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Ubiquitylation of Groucho/TLE does not affect its turnover, localization, or 
capacity to tetramerize 
Having established that XIAP binds and ubiquitylates TLE3, we next 
asked how ubiquitylation of TLE3 might affect its function in the Wnt pathway. 
Ubiquitylation of proteins often serves as a signal for proteasomal degradation 
(Ravid and Hochstrasser, 2008). Thus, we sought to determine if gain or loss of 
XIAP has any effect on TLE3 levels. Neither overexpression nor siRNA 
knockdown of XIAP had any effect on the steady-state levels of TLE3 either in 
the presence or absence of Wnt stimulation (Figure 4.11A and B). Furthermore, 
overexpression and siRNA knockdown of XIAP had no effect on the turnover rate  
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of TLE3 (Figure 4.11C and D). The stabilization of XIAP seen in Figure 4.11C is 
likely due to overwhelming of the endogenous XIAP degradation machinery 
caused by the significant overexpression of XIAP. These results indicate that 
ubiquitylation of TLE3 by XIAP does not affect TLE3 stability. 
 Recent studies have shown a role for mono-ubiquitylation in regulating the 
subcellular localization of transcription factors (Dupont et al., 2009; Li et al., 
2003; van der Horst et al., 2006). Thus, we examined whether siRNA knockdown 
of XIAP has any effect on the nuclear localization of TLE3. Prominent nuclear 
staining of TLE3 could be detected in both control and XIAP-siRNA cells (Figure 
Figure 4.11. Ubiquitylation of Groucho/TLE by XIAP does not affect its 
stability, nuclear localization, or capacity to tetramerize.  
(A and B) Overexpression or knockdown of XIAP in cultured mammalian cells 
does not affect steady-state Groucho/TLE levels. HEK293 cells were 
transfected with vector control (Con) or XIAP expression plasmid (A) or with 
control (Con) or XIAP siRNA (B) as indicated, treated with L-CM or Wnt3a-CM, 
and immunoblotting performed. 
(C and D) Overexpression or knockdown of XIAP does not affect the rate of 
Groucho/TLE turnover. HEK293 cells were transfected with vector control or 
XIAP expression plasmid (C) or with control or XIAP siRNA (D) followed by 
treatment with cyclohexamide (CHX). Cells were then harvested at the 
indicated time points for immunoblotting.  
(E) Knockdown of XIAP does not affect Groucho/TLE nuclear localization. 
HEK293 cells were transfected with control (Con) or XIAP siRNA and 
immunostained for TLE3. No change in TLE3 localization was observed. 
Greater than 300 cells were scored per condition. Scale bars, 5 µm.  
(F) Ubiquitylation of Groucho/TLE does not affect its capacity to tetramerize. In 
vitro-translated full-length TLE3 (Top) or TLE3-Q (Bottom) proteins (both myc-
tagged) were ubiquitylated in vitro and resolved by gel filtration. Fractions were 
immunobloted with anti-myc antibody. Asterisks indicate ubiquitylated species. 
Elution profiles of protein standards are indicated by arrows. GADPH is 
loading control in (A-E).  
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4.11E), indicating loss of XIAP does not cause a shift in the subcellular 
localization of TLE3. Overexpression of XIAP similarly does not result in a shift in 
the nuclear localization of TLE3 (data not shown).  
TLE3 is a member of the highly conserved Gro/TLE family of proteins that 
function as transcriptional co-repressors in the Wnt pathway. Five isoforms of 
TLE proteins have been identified in humans (Gasperowicz and Otto, 2005). By 
performing the same ubiquitylation assay as described above (Figure 4.6C), we 
demonstrated that XIAP has the capacity to ubiquitylate all human TLE isoforms, 
including the truncated isoform Amino-terminal enhancer of split (AES) (Figure 
4.12A). Because AES only contains the first 197 amino acids found in full-length 
TLE isoforms (including the N-terminal glutamine-rich (Q) and Glycine-Proline 
rich (GP) domains), this narrows the potential target sites of XIAP-mediated 
ubiquitylation to this region of the TLE proteins (Figure 4.12C). We further 
narrowed the potential XIAP target sites by demonstrating that recombinant XIAP 
can ubiquitylate recombinant Drosophila Groucho Q domain in vitro (Figure 
4.12B).  The Q domains of Gro/TLE proteins are highly conserved and contain 
eight lysines that are present in Drosophila Gro and all human TLE isoforms 
(Figure 4.12C and D). Thus, based on our results, XIAP likely targets one (or 
two) of the conserved lysines in the Q domain of the Gro/TLE proteins.  
Mapping the potential XIAP-mediated ubiquitylation sites on Gro/TLE to 
the Q domain provided clues regarding the functional consequence of this 
modification. Gro/TLE proteins have been shown to homo-tetramerize through 
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their Q-domain, a property that is required for TCF/Lef binding and for mediating 
transcriptional repression (Gasperowicz and Otto, 2005; Jennings and Ish-
Horowicz, 2008). Thus, we next tested if ubiquitylation of TLE3 by XIAP disrupts 
its capacity to tetramerize by assessing the hydrodynamic properties of in vitro-
translated ubiquitylated and non-ubiquitylated species of TLE3. We analyzed the 
effect of XIAP-mediated ubiquitylation on both the N-terminal Q domain of TLE3 
(TLE3-Q) and full-length TLE3 by performing gel-filtration analysis (Figure 
4.11F). We found that the ubiquitylated forms of TLE3-Q and full-length TLE3 
eluted in the same peak fractions as that of their non-ubiquitylated forms, 
indicating that ubiquitylation of TLE3 does not disrupt its capacity to tetramerize. 
The larger than expected apparent molecular weight of TLE3-Q and full-length 
TLE3 on gel filtration chromatography likely reflects an elongated tetrameric 
protein complex and has been previously reported (Kuo et al., 2010). 
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Figure 4.12. XIAP ubiquitylates all human TLE isoforms and Drosophila 
Groucho. 
(A) XIAP ubiquitylates all human TLE isoforms. HEK293 cells were transfected as 
indicated, His-ubiquitylated proteins were isolated and analyzed by 
immunoblotting.  
(B) XIAP ubiquitylates Drosophila Groucho Q domain. Recombinant SUMO-His6-
Groucho-Q was used in an in vitro XIAP ubiquitylation reaction.  
(C) Cartoon of Drosophila Groucho and human TLE isoforms. Percentage identity 
of the Q-domains of human TLE/AES compared to the Q-domain of Drosophila 
Groucho is indicated.  
(D) Amino acid sequence alignment of the Drosophila Groucho and human TLE Q 
domains is shown. Identical amino acids are shaded in yellow. Asterisks indicate 
conserved lysine residues.  
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Ubiquitylation of Groucho/TLE by XIAP disrupts its binding to TCF/Lef 
Although we found that ubiquitylation of TLE3 did not interfere with its 
tetramerization in our hydrodynamic studies, we hypothesized ubiquitylation of 
TLE3 may interfere with its capacity to bind TCF/Lef as Gro/TLE interacts with 
TCF/Lef via its Q domain. To test this possibility, we ubiquitylated TLE3-Q and 
full-length TLE3 in vitro and assessed their capacity to bind TCF4. In contrast to 
their non-ubiquitylated forms, the ubiquitylated species of TLE3-Q and full-length 
TLE3 were not pulled down by recombinant GST-TCF4 protein, indicating that 
ubiquitylation of TLE3 inhibits its capacity to bind TCF4 (Figure 4.13A). To further 
confirm that TCF/Lef has reduced affinity for ubiquitylated Gro/TLE in vivo, myc-
TLE3 and HA-TCF4 were transfected into cells (along with ubiquitin and XIAP to 
enhance TLE3 ubiquitylation) (Figure 4.13B). The presence of ubiquitylated or 
non-ubiquitylated TLE3 in HA-TCF4 immunoprecipitates was assessed by 
immunoblotting. In contrast to total cellular lysates, which contained a noticeable 
band representing ubiquitylated TLE3, only the non-ubiquitylated TLE3 co-
immunprecipiated with TCF4, thereby providing further evidence that 
ubiquitylation of Gro/TLE inhibits its capacity to bind TCF/Lef.  
These findings suggest that ubiquitylation of TLE3 by XIAP may be 
required during Wnt pathway activation to remove TLE3 from TCF/Lef, allowing 
subsequent β-catenin binding and transcriptional activation. To determine if XIAP 
might also bind TCF/Lef in the process of binding and ubiquitylating Gro/TLE, we 
performed an in vitro binding assay with recombinant XIAP and TCF4. We found 
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that XIAP is pulled down with TCF4, but not the control, indicating XIAP can 
directly bind TCF4 (Figure 4.13C). In contrast to Gro/TLE, however, we were 
unable to detect ubiquitylation of TCF4 by XIAP in an in vitro ubiquitylation assay 
(Figure 4.13D), indicating specificity of the E3 ubiquitin ligase activity of XIAP for 
Gro/TLE. 
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Figure 4.13.  Ubiquitylation of Groucho/TLE by XIAP disrupts TCF/Lef 
binding.  
(A) Ubiquitylation of Groucho/TLE disrupts TCF/Lef binding in vitro. In vitro-
translated full-length myc-TLE3 (Top) or myc-TLE3-Q (Bottom) proteins were 
ubiquitylated in vitro and tested in an in vitro binding assay with recombinant 
GST-TCF4 or GST proteins immobilized on glutathione beads. myc-TLE3 was 
visualized by immunoblotting with anti-myc antibody. Arrowheads indicate 
ubiquitylated species.  
(B) Ubiquitylation of Groucho/TLE disrupts TCF/Lef binding in cultured cells. 
HEK293 cells were transfected with Flag-XIAP, His-Ub, myc-TLE3 and HA-
TCF4. HA-TCF4 was immunoprecipitated with anit-HA antibody and co-
immunoprecipitated myc-TLE3 was detected by immunoblotting. IgG antibody 
(Con) was used as control.  
(C) XIAP directly interacts with TCF4. An in vitro binding assay was performed 
using recombinant MBP-tagged XIAP and either recombinant GST-TCF4 or 
GST proteins immobilized on glutathione beads. XIAP was detected using an 
anti-XIAP antibody.  
(D) XIAP fails to ubiquitylate TCF/Lef. An in vitro XIAP ubiquitylation assay 
was performed with in vitro-translated HA-TCF4 as the test substrate. In 
parallel, ubiquitylation of myc-TLE3 was observed (positive control, data not 
shown). 
(E and F) XIAP is recruited to TCF/Lef and is required for efficient binding of 
TCF/Lef to β-catenin upon Wnt pathway activation. (E) HEK293 cells 
transfected with control (Con) or XIAP siRNA were treated with 30 mM LiCl for 
3 hrs and endogenous TCF4 immunoprecipitated.  Co-immunoprecipitated 
endogenous β-catenin and XIAP were detected by immunoblotting. (F) 
HEK293 cells were treated as in (E) except L-CM or Wnt3a-CM was added for 
3 hrs.  
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If XIAP ubiquitylates Gro/TLE in response to a Wnt signal in order to 
remove it from TCF/Lef, one might predict that ubiquitylation of Gro/TLE would 
increase upon Wnt signaling. We detected no change, however, in the degree of 
Gro/TLE ubiquitylation in response to Wnt stimulation (Figure 4.14). Because we 
also found that XIAP interacts with TLE3 in the absence or presence of Wnt 
signaling (Figure 4.6B), this would suggest that XIAP constitutively binds and 
ubiquitylates non-TCF-bound Gro/TLE in the nucleus.  Thus, XIAP may regulate 
the nuclear pool of Gro/TLE that is available for binding TCF/Lef. 
Given that XIAP binds TCF4, it is possible that XIAP may be recruited to 
the TCF/Lef transcriptional complex to specifically ubiquitylate TCF-bound 
Figure 4.14. Wnt signaling does not increase TLE3 ubiquitylation. 
HEK293 cells were transfected with myc-TLE3 and His-Ub and treated with 
L-CM or Wnt3a-CM. His-ubiquitylated proteins were isolated and analyzed 
by immunoblotting. 
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Gro/TLE upon Wnt pathway activation. To test whether XIAP is recruited to the 
TCF/Lef transcriptional complex in a Wnt-dependent manner, we performed co-
immunoprecipitation assays in cells using an antibody against endogenous TCF4 
(Figure 4.13E and F). In the absence of lithium (Figure 4.13E), XIAP was not 
detectable in TCF4 immunoprecipitates. Upon Wnt pathway stimulation by 
lithium, however, XIAP co-immunoprecipitated with TCF4. Wnt pathway 
activation normally leads to recruitment of β-catenin onto TCF/Lef. Accordingly, 
we observed endogenous β-catenin co-immunoprecipitating with TCF4 upon 
lithium treatment whereas no detectable β-catenin co-immunoprecipitated with 
TCF4 in the absence of lithium treatment.  Significantly, knockdown of XIAP by 
siRNA reduced the amount of β-catenin that co-immunoprecipitated with TCF4 in 
the presence of lithium. These results were confirmed using Wnt3a-conditioned 
media, suggesting this is not due to global inhibition of GSK3 activity (Figure 
4.13F). These data indicate XIAP is recruited to TCF4 transcriptional complexes 
in response to Wnt pathway activation and that XIAP is required for efficient 
recruitment of β−catenin to TCF4 transcriptional complexes.  
Together, our data suggest a model (Figure 4.15) in which XIAP 
constitutively binds and ubiquitylates non-TCF-bound Gro/TLE in the nucleus, 
thereby limiting the amount of Gro/TLE available to form co-repressor complexes 
with TCF/Lef. In the presence of a Wnt signal, XIAP is recruited to TCF/Lef 
transcriptional complexes where it ubiquitylates Gro/TLE.  Ubiquitylation of 
Gro/TLE decreases its affinity for TCF/Lef and allows for the efficient recruitment 
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and binding of the transcriptional co-activator β-catenin to TCF/Lef in order to 
initiate a Wnt-specific transcriptional program. 
 
 
Summary 
 A key event in Wnt signaling is conversion of TCF/Lef from a transcriptional 
repressor to an activator, yet how this switch occurs is not well understood. Here, 
we report an unanticipated role for X-linked Inhibitor of Apoptosis (XIAP) in 
regulating this critical Wnt signaling event that is independent of its anti-apoptotic 
function. We identified DIAP1 as a positive regulator of Wingless signaling in a 
Drosophila S2 cell-based RNAi screen. XIAP, its vertebrate homolog, is similarly 
required for Wnt signaling in cultured mammalian cells and in Xenopus embryos, 
indicating evolutionary conservation of function. Upon Wnt pathway activation, 
XIAP is recruited to TCF/Lef where it mono-ubiquitylates Groucho/TLE: this 
Figure 4.15.  Model of XIAP-mediated regulation of Groucho/TLE in the 
Wnt pathway.   
See text for details. 
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modification decreases the affinity of Groucho/TLE for TCF/Lef. Our data reveal 
a transcriptional switch involving XIAP-mediated ubiquitylation of Groucho/TLE 
that facilitates its removal from TCF/Lef, thus allowing assembly of β-catenin-
TCF/Lef complexes and initiation of a Wnt-specific transcriptional program. 
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CHAPTER V 
 
THE DUB USP47 IS REQUIRED FOR WNT SIGNALING 
 
Introduction 
The canonical Wnt signaling pathway regulates many fundamental 
processes during metazoan development and is critical for tissue homeostasis in 
the adult (Logan and Nusse, 2004; MacDonald et al., 2009).  A key event in Wnt 
signal transduction is the stabilization of the cytoplasmic protein β-catenin.  In the 
absence of a Wnt ligand, a β-catenin destruction complex, composed of Axin, 
glycogen synthase kinase 3 (GSK3), casein kinase I α (CKIα), and the tumor 
suppressor adenomatous polyposis coli (APC), promotes phosphorylation of β-
catenin, targeting it for ubiquitin-mediated proteasomal degradation.  Binding of a 
Wnt ligand to its two cell-surface receptors, Frizzled (Fz) and LDL receptor-
related protein 5/6 (LRP5/6), results in inhibition of β-catenin phosophorylation 
and, thus, stabillzation of β-catenin. Stabilized β-catenin translocates to the 
nucleus where it binds to TCF/Lef to activate a Wnt-specific transcriptional 
program. 
The Wnt pathway is heavily regulated by ubiquitylation (Tauriello and 
Maurice, 2010).  At the time I began these studies, however, only the E3 ligases 
for β-catenin (Jiang and Struhl, 1998; Marikawa and Elinson, 1998) and 
Dishevelled (Angers et al., 2006) had been identified, and no deubiquitylases 
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(DUBs) in the Wnt pathway had been reported.  Thus, I sought to identify novel 
DUBs involved in Wnt signaling to gain a better understanding of how the 
ubiquitin system regulates this pathway. 
Here, I performed a targeted RNAi screen in Drosophila S2 cells to identify 
novel DUBs involved in Wingless (Wg, the Drosophila homolog of Wnt) signal 
transduction that led to the identification of Ubiquitin-specific protease 64 E 
(Ubp64E) as a critical Wg pathway component.  I demonstrate that the human 
homolog, Ubiquitin Specific Protease 47 (USP47), is similarly required for Wnt 
signaling in cultured human cells and is required for primary body axis formation 
in Xenopus embryos, indicating evolutionary conservation of function.  At the 
molecular level, I show that USP47 interacts with two Wnt pathway E3 ligases, β-
TRCP and XIAP, although this interaction does not affect the stability of β-TRCP 
or XIAP.  Together, these studies identify USP47 as a novel DUB involved in the 
regulation of Wnt signal transduction and provide insight into its potential 
mechanism of action.     
 
Results 
 
Drosophila RNAi screen identifies the DUB Ubp64E as a novel Wingless 
signaling component. 
To identify novel de-ubiquitylases (DUBs) involved in Wingless (Wg) 
signaling, I performed a genome-scale RNAi-based screen targeting DUBs in 
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Drosophila S2 cells (Figure 5.1A, see Chapter II for details). Briefly, plasmids 
encoding experimentally verified and predicted DUBs (29 clones total) were 
obtained from the Drosophila Gene Collection Release 1 and 2, and a PCR 
approach was used to generate linear cDNA products suitable for in vitro dsRNA 
synthesis. For the screen, dsRNA was added to a Drosophila S2R+ reporter cell 
line stably transfected with the Wg responsive TOPflash luciferase reporter 
(Korinek et al., 1997). 
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 Axin (a potent negative regulator of Wg signaling) and Armadillo (Arm, the 
Drosophila β-catenin homolog and potent positive regulator of Wg signaling) 
served as controls to confirm effective knockdown by dsRNA treatment in the 
screen Of the 29 DUBs screened, the knockdown of two, no. 11 and no. 15, were 
particularly potent in inhibiting Wg signaling (Figure 5.1B).  dsRNA no. 11 targets 
Cylandromatosis (CYLD), a DUB that had been reported as a Wnt signaling 
regulator at the “Wnt Singaling in Development and Disease Meeting” (Berlin, 
Germany, 2007).  Thus, I decided to focus on the other DUB, no. 15, which 
encodes Ubiquitin-specific protease 64E (Ubp64E), a putative DUB that had no 
known function at the time I began this work.   
  
Figure 5.1. Drosophila RNAi screen identifies the DUB Ubp64E as a novel 
Wingless signaling component.  
(A) Schematic of RNAi screen to identify DUBs that regulate Wingless signaling 
in Drosophila S2 cells (see text for more details).  
(B) Results of RNAi screen. Graph represents mean ± standard deviation (SD) 
of TOPflash normalized to cell number. Axin and Armadillo (Arm) dsRNA 
treatments were performed as controls. Results for Ubp64E dsRNA (15) and 12 
additional dsRNAs included in the screen are shown. Results are representative 
of at least three experiments performed in quadruplicate.  
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Figure 5.2.  USP47 is required for Wnt signaling in cultured mammalian 
cells.  
(A) Knockdown of USP47 by siRNA inhibits Wnt signaling.  HEK293 STF 
(STF293) cells were transfected with non-targeting control (Con) or two 
independent USP47 siRNAs and treated with L cell (L-CM) or Wnt3a cell- 
(Wnt3a-CM) conditioned media for 24 hrs. Graph shows mean ± SD of 
TOPflash normalized to cell number. Immunoblotting confirmed knockdown 
of XIAP protein and Wnt3a-mediated stabilization of β-catenin. GAPDH is 
loading control.  
(B) Overexpression (OE) of USP47 enhances TOPflash activity.  STF293 
cells were transfected with USP47 or USP47-mut and treated with L-CM or 
Wnt3a-CM for 24 hrs. Graph shows mean ± SD of TOPflash activity 
normalized to cell number.  
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USP47 is required for Wnt signaling in cultured mammalian cells. 
 To determine if USP47, the human homolog of Ubp64E, is similarly 
required for Wnt signaling in mammalian cells, I next tested the effects of USP47 
knockdown on Wnt3a-induced transcriptional activation using a human 
embryonic kidney (HEK) 293 cell line stably transfected with the TOPflash 
reporter (STF293) (Xu et al., 2004). Knockdown of USP47 with two independent 
short-interfering RNA (siRNA) constructs blocked Wnt3a-induced TOPflash 
activation (Figure 5.2A), indicating that USP47 is required for Wnt-mediated 
transcriptional activation.  Notably, knockdown of USP47 did not change the 
levels of cytoplasmic β-catenin, suggesting that USP47 is likely functioning 
downstream of the β-catenin destruction complex (Figure 5.2A).   
In contrast to loss of USP47 function, overexpression of USP47 activated 
Wnt signaling in STF293 cells to a similar extent as β-catenin overexpression, 
while the catalytically dead USP47 mutant (in which the active site cysteine has 
been mutated to an alanine) inhibited Wnt signaling similar to overexpression of 
the potent negative regulator Axin (Figure 5.2B).  This suggests that the DUB 
activity of USP47 is required for its capacity to activate Wnt signaling and that the 
catalytically dead USP47 mutant acts as a dominant negative Wnt signaling 
inhibitor.  Together, these results indicate that the DUB activity of USP47 is 
required for Wnt signaling and that USP47 likely functions downstream of the β-
catenin destruction complex in the Wnt pathway.   
 
 101 
USP47 is localized in the cytoplasm 
 To determine where USP47 is found in the cell, I first expressed GFP-
USP47 in HEK293 cells and visualized its localization using fluorescence 
microscopy (Figure 5.3A).  GFP-USP47 is localized predominantly in the 
cytoplasm while the GFP control is found throughout the cell.  The localization 
pattern of GFP-USP47 did not change in the presence of Wnt signaling (data not 
shown).  Interestingly, GFP-USP47 is found at the leading edge of the cell in 
what appear to be lamellipodial structures (Alberts, 2002), although more specific 
co-staining (e.g. with actin) is needed to prove the leading edge structures are 
indeed lamellipodia.  This localization pattern is consistent with the findings of 
Rorth and colleagues who showed that Ubp64E is critical for border cell 
migration during Drosophila oogenesis by regulating the stability of the 
transcription factor Slowborders (Slbo) (Rorth et al., 2000).  Thus, Ubp64E and 
USP47 may play important roles in cell migration in both Drosophila and 
mammalian cells, respectively.    
 In addition to the fluorescence imaging studies, cellular fractionation and 
Western blot analysis also indicated that USP47 is found predominantly in the 
nucleus; a localization that does not change upon Wnt stimulation (Figure 5.3B).  
These findings indicate that USP47 is predominantly a cytoplasmic protein and 
that Wnt signaling does not affect its subcellular localization. 
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Figure 5.3.  USP47 is located in the cytoplasm. 
(A) HEK293 cells transfected with GFP-USP47 or GFP control were fixed and 
visualized with immunofluorescence microscopy.  
(B) HEK293 cells were treated with LiCl (30 mM) as indicated for 24 hr, 
fractionated, and immunoblotted as indicated.   
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USP47 is expressed throughout Xenopus development 
 To determine if USP47 plays a critical role in Wnt signaling in a whole 
organism, I used the classic Wnt model system Xenopus laevis.  Before 
performing loss or gain-of-function studies in Xenopus, however, I first 
determined when and where USP47 is expressed during Xenopus development.  
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis using 
primers specific for Xenopus USP47 (XUSP47) showed that XUSP47 is 
expressed at all developmental time points tested (Figure 5.4A). 
 In situ hybridization analysis with an anti-sense probe targeting XUSP47 
similarly showed that XUSP47 is expressed at all time points tested during 
Xenopus development and that it is dynamically localized in a manner similar to 
the key Wnt component, β-catenin (Figure 5.4B-H) (β-catenin images from 
(DeMarais and Moon, 1992)).  Figure 5.4B-E shows XUSP47 is localized to the 
animal half of the early embryo.  At the neurula stage (Figure 5.4F), XUSP47 is 
primarily localized to the anterior (right) and posterior (left) ends of the embryo 
similar to Xβ-catenin, while at the tail bud stage (Figure 5.4G) XUSP47 is 
localized to the branchial arches, the eye, and the posterior end of the embryo, 
also similar to Xβ-catenin.  At the tadpole stage (Figure 5.4H), XUSP47 is 
localized to the head and spinal cord, again similar to Xβ-catenin.  Together, 
these studies indicate that XUSP47 is expressed during Xenopus development in 
a manner that is consistent with USP47 being a Wnt signaling regulator.    
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USP47 affects primary body axis formation in Xenopus embryos. 
 Once I had established that XUSP47 is expressed in the early Xenopus 
embryo in a manner consistent with Wnt pathway regulation, I next tested if loss 
or gain of USP47 function is able to perturb primary body axis formation in 
Xenopus embryos; a process critically regulated by Wnt signaling (Heasman, 
2006).  Knockdown of USP47 by dorsal injection of a USP47 morpholino resulted 
in severely ventralized embryos, consistent with Wnt pathway inhibition (Figure 
5.5A).  This phenotype was rescued by co-injection of mouse USP47 mRNA with 
the USP47 morpholino indicating the observed phenotype is specifically due to 
USP47 knockdown and not some other non-specific morpholino effect.   
 Overexpression of USP47 by ventral injection of USP47 mRNA resulted in 
partial axis duplication, consistent with Wnt pathway activation (Figure 5.5B).  To 
examine the partially duplicated axes in more detail, the embryos were sectioned 
and stained with hematoxylin and eosin (Figure 5.5C).  These studies revealed 
that the primary tissue induced by USP47 injection is mesodermal tissue and that 
Figure 5.4.  USP47 is dynamically expressed throughout Xenopus 
development.   
(A) RT-PCR analysis of XUSP47 expression during Xenopus development.  
Embryos were collected at the indicated stages, RNA extracted, and RT-
PCR performed. Ornithine decarboxylase (ODC) is loading control.  
(B-H) In situ hybridization detects dynamic XUSP47 expression throughout 
Xenopus development.  (B) Egg, (C) 2-cell stage, (D) 4-cell stage, (E) 
Stage 10-11, (F) Neurula stage, (G) Tailbud stage, (H) Tadpole stage.  Red 
arrows point to pharyngeal arches (1) and eye (2).  Images of Xβ-catenin In 
situs are from (DeMarais and Moon, 1992).  
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the partial secondary axes induced by USP47 injection look nearly identical to 
those induced by injection of a small amount of Xwnt8 mRNA, further indicating 
that overexpression of USP47 activates Wnt signaling in Xenopus embryos.   
To further confirm that USP47 is capable of inducing ectopic head 
organizer formation, I tested the capacity of USP47 to induce the expression of 
the classic organizer marker Chordin.  Injection of USP47 mRNA into Xenopus 
animal caps induced the expression of Chordin to a greater extent than injecting 
a small amount of Xwnt8 (a key organizer inducer) (Figure 5.5D).  Co-injection of 
Xwnt8 with USP47 did not result in enhanced Chordin expression, indicating 
these two molecules do not synergize.  Together, these results indicate that 
USP47 is required for proper axis formation and that USP47 is capable of ectopic 
organizer formation in Xenopus embryos; two features consistent with USP47 
playing a critical role in Wnt signaling during Xenopus development.   
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USP47 interacts with β-TRCP and Smad4, but does not affect their stability 
 Having demonstrated that USP47 regulates Wnt signaling across phyla, I 
next sought to elucidate the molecular mechanism of its function in the Wnt 
pathway.  Work in Drosophila indicated that Ubp64E interacts with Slimb (the 
Drosophila homolog of β-TRCP, the E3 ligase that targets β-catenin for 
proteasomal degradation) (Bajpe et al., 2008).  Thus, I tested if USP47 also 
interacts with β-TRCP in mammalian cells by overexpressing USP47 and myc-
β−TRCP and performing a co-immunoprecipitation experiment in the presence 
and absence of Wnt stimulation.  The results indicate that USP47 co- 
Figure 5.5. Loss and gain of USP47 perturbs axis formation in Xenopus 
embryos.  
(A) USP47 is required in Xenopus embryos for primary body axis formation. 
Embryos (4-cell stage) were injected dorsally with control (Con MO), USP47 
morpholino (USP47 MO) alone (25 ng), or USP47 MO and USP47 mRNA (2 
ng) and dorsal-anterior index (DAI) determined (Kao and Elinson, 1988). The 
percentage of ventralized embryos (DAI <= 2) is graphed on the left 
(absolute numbers above bars) with representative embryos on the right.  
(B) USP47 induces secondary axis formation. Embryos (4-cell stage) were 
injected ventrally with control (Con) or USP47 mRNA (2 ng) and allowed to 
develop. The percentage of embryos with secondary axis formation is 
graphed on the left (absolute numbers above bars) with representative 
embryos on the right.  
(C) USP47 induces mesoderm formation. Embryos treated as in (B) were 
fixed, sectioned, and stained with hemotoxylin and eosin.  NT = Neural Tube, 
NC = Notochord.  Arrows point to induced mesoderm in both the USP47- 
and Xwnt8-injected embryos.  
(D) USP47 induces expression of the head organizer marker Chordin in 
Xenopus ectodermal explants. Total RNA was extracted from animal caps 
injected with Xwnt8 mRNA (0.35 pg), USP47 mRNA (2 ng), or both and 
Chordin gene expression was assayed by RT-PCR. WE = whole embryo 
control. Ornithine decarboxylase (ODC) is loading control.  
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immunoprecipitates with β-TRCP in both the absence and presence of Wnt  
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signaling (Figure 5.6A).  Peschiaroli and colleagues recently reported that USP47 
interacts with β-TRCP via the β-TRCP WD40-repeat region (Peschiaroli et al., 
2010), confirming that USP47 and β-TRCP are associated in mammalian cells.   
 That USP47 (a DUB) interacts with β-TRCP (an E3 ligase) is not 
surprising given that most E3s are associated with DUBs, which often function to 
regulate the stability of their partner E3s (Sowa et al., 2009).  However, 
overexpression of USP47 does not have any observable effect on the steady 
state levels of β-TRCP (Figure 5.6C).  Loss (Figure 5.2A) or gain (Figure 5.6C) of 
USP47 also has no effect on the steady state levels of the most well 
characterized Wnt pathway β-TRCP substrate, β-catenin.  Thus, USP47 does not 
likely regulate the stability of β-TRCP or β-catenin in the Wnt pathway.     
Given that USP47 interacts with β-TRCP, I next sought to determine if β-
TRCP has other Wnt-relevant substrates in addition to β-catenin.  One group has 
Figure 5.6.  USP47 interacts with β-TRCP and Smad4. 
(A) USP47 interacts with β-TRCP.  HEK293 cells were transfected with 
USP47 and myc-β-TRCP and treated with Wnt3a-CM. Cells were lysed 
and USP47 immunoprecipitated. Co-immunoprecipitated β-TRCP was 
detected by anti-myc antibody.  
(B) USP47 interacts with Smad4.  HEK293 cells were transfected with 
Smad4 and USP47 and treated with L-CM or Wnt3a-CM for 3 hrs, lysed, 
and immunoprecipitated with anti-USP47 antibody. Co-immunoprecipitated 
Smad4 was detected by anti-Smad4 antibody.  
(C) Overexpression of USP47 in cultured mammalian cells does not affect 
steady-state β-TRCP, Smad4, or β-catenin levels. HEK293 cells were 
transfected with vector control (Con) or USP47 expression plasmid as 
indicated, treated with L-CM or Wnt3a-CM, and immunoblotting performed. 
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shown that β-TRCP also ubiquitylates Smad4, targeting it for proteasomal 
degradation (Wan et al., 2004).  This is interesting as work performed by Josh 
Smith in the Beauchamp laboratory (Vanderbilt University, personal 
communication) indicated that Smad4 inhibits Wnt signaling in colorectal cancer 
cells, potentially through downregulation of β-catenin transcription.  This 
hypothesis was confirmed by a group showing that restoring Smad4 expression 
in SW480 cells (colorectal cancer cells containing a mutant, truncated APC 
protein) suppresses Wnt signaling by decreasing β-catenin expression and re-
localizing β-catenin to the plasma membrane (Tian et al., 2009).  These studies 
indicated the existence of cross-talk between Smad4 (traditionally thought of as a 
TGF-β or BMP pathway component) and Wnt signaling.  Thus, I performed a co-
immunoprecipitation experiment to determine if USP47 interacts with Smad4.  
For this, USP47 and Smad4 were overexpressed in the absence and presence of 
Wnt signaling.  USP47 was immunoprecipitated and co-immunoprecipitated 
Smad4 was detected with anti-Smad4 antibody.  The results indicate that USP47 
interacts with Smad4 in both the absence and presence of Wnt signaling (Figure 
5.6B), however, overexpression of USP47 has no observable effect on the 
steady state levels of Smad4, indicating that USP47 does not affect Smad4 
stability (Figure 5.6C).  Together, these findings indicate a possible role for β-
TRCP or Smad4 as part of the molecular mechanism of USP47 in the Wnt 
pathway.   
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USP47 interacts with XIAP, but does not affect TLE3 or XIAP stability. 
In addition to binding the E3 ligase β-TRCP, data I collected in a mass 
spectrometry screen to identify USP47 binding partners indicated that USP47 
might also interact with the E3 ligase XIAP.  One of the USP47 binding partners 
identified in the mass spectrometry screen was Apoptosis Inhibitory Factor (AIF), 
which has been shown to interact with XIAP, the E3 ligase that mono-
ubiquitylates Groucho/TLE (see Chapter III) (mass spectrometry data not 
shown).  Thus, I tested if USP47 associates with XIAP by performing a co-
immunoprecipitation experiment with overexpressed, tagged versions of both 
proteins.  Figure 5.7A shows that XIAP is immunoprecipitated with USP47 when 
both proteins are expressed together, but not when they are expressed alone,  
 
Figure 5.7.  USP47 interacts with XIAP. 
(A) Tagged USP47 co-immunoprecipitates with tagged XIAP. HEK293 cells 
were transfected as indicated with HA-USP47 and myc-XIAP and treated 
with Wnt3a-CM. Cells were lysed and USP47 immunoprecipitated with anti-
HA antibody. Co-immunoprecipitated XIAP was detected by anti-myc 
antibody.  
(B) Endogenous USP47 co-immunoprecipitates with tagged XIAP. HEK293 
cells were transfected with Flag-XIAP, lysed, and immunoprecipitated with 
anti-XIAP antibody. Co-immunoprecipitated USP47 was detected with anti-
USP47 antibody.  
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indicating a specific interaction.  The interaction between USP47 and XIAP was 
confirmed by demonstrating that endogenous USP47 co-immunoprecipitates with 
tagged XIAP (Figure 5.7B).   
Given that XIAP ubiquitylates Groucho/TLE, and that many DUBs regulate 
the stability of their partner E3s, I next sought to determine if loss of USP47 
function affects the steady state levels of TLE3 or XIAP.  Figure 5.8A shows that 
knockdown of USP47 with two independent siRNA constructs has no observable 
effect on the steady state levels of either TLE3 or XIAP.  Overexpression of 
USP47 also has no observable effect on the steady state levels of TLE3 or XIAP  
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Figure 5.8.  USP47 and XIAP do not affect the stability of each other. 
(A)  Knockdown of USP47 in cultured mammalian cells does not affect steady-
state XIAP or TLE3  levels.  HEK293 cells were transfected with non-targeting 
control (Con) or two independent USP47 siRNAs (USP47-1 and USP47-2) as 
indicated, and immunoblotting performed. 
(B and C)  Overexpression or knockdown of XIAP in cultured mammalian cells 
does not affect steady-state USP47 levels. HEK293 cells were transfected 
with vector control (Con) or XIAP expression plasmid (B) or with control (Con) 
or XIAP siRNA (C) as indicated, treated with L-CM or Wnt3a-CM, and 
immunoblotting performed. 
(D)  XIAP does not ubiquitylate USP47 in vitro. In vitro-translated USP47 was 
incubated in an in vitro ubiquitylation assay with recombinant proteins as 
indicated and visualized by immunoblotting with anti-USP47 antibody.  
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(data not shown).  These data indicate that USP47 does not regulate the stability 
of the E3 ligase XIAP or its Wnt pathway substrate, Groucho/TLE. 
To determine if gain or loss of XIAP may affect USP47 stability, I 
overexpressed XIAP (Figure 5.8B) or knocked down XIAP with two independent 
siRNA constructs (Figure 5.8C) and saw no observable changes in the steady 
state levels of USP47.  These data indicate that XIAP does not affect the stability 
of USP47.  These findings are consistent with the finding that XIAP does not 
ubiquitylate USP47 in vitro in the same assay in which XIAP efficiently 
ubiquitylates TLE3 (Figure 5.8D and see Chapter III, Figure 4.6F).  These results 
indicate that USP47 is not a XIAP substrate.   
 
Summary 
 Canonical Wnt signaling regulates many fundamental developmental 
processes and is misregulated in a variety of disease states in humans.  The 
central event of Wnt signal transduction is the stabilization of the cytoplasmic 
protein β-catenin.  When stabilized, β-catenin enters the nucleus to activate a 
Wnt-specific transcriptional program by binding to the Wnt transcription factor 
TCF/Lef.  Here, we identified the de-ubiquitylase Ubp64E as a positive regulator 
of Wingless (the Drosophila Wnt homolog) signaling in a Drosophila S2 cell-
based RNAi screen.  USP47, its vertebrate homolog, is similarly required for Wnt 
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signaling in cultured mammalian cells and in Xenopus embryos, indicating 
evolutionary conservation of function.  Our data indicate that USP47 likely 
functions at the level of transcription in the nucleus potentially through its 
interaction with the E3 ligases β-TRCP or XIAP or an as yet unidentified target.   
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CHAPTER VI 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
Introduction 
 The work presented in this thesis describes the identification of two novel 
ubiquitin system components involved in regulating Wnt signaling:  the E3 ligase 
XIAP and the de-ubiquitylase USP47.  Here, I will discuss the results presented 
in the last two chapters and provide future directions.  I have broken this chapter 
into two parts.  In Part I I discuss the implications of XIAP as a Wnt pathway 
regulator and in Part II I discuss the implications of USP47 as a Wnt pathway 
regulator.  I conclude with a general discussion of the significance of my findings. 
 
Part I 
 
Discussion 
Conversion of the Wnt transcription factor TCF/Lef from a transcriptional 
repressor to a transcriptional activator is a critical event in Wnt signal 
transduction, yet our understanding as to how this switch occurs in cells is limited. 
The current model, based primarily on reconstitution studies using purified 
proteins, proposes direct displacement of the transcriptional co-repressor Gro/TLE 
by the co-activator β-catenin through competition for overlapping binding sites on 
 118 
TCF/Lef (Daniels and Weis, 2005). Here, we provide evidence for a more finely 
tuned transcriptional switch that involves the facilitated removal of Gro/TLE from 
TCF/Lef upon its ubiquitylation by the E3 ligase XIAP.  
Our data suggest a model (Figure 6.1) in which XIAP constitutively binds 
and ubiquitylates non-TCF-bound Gro/TLE in the nucleus, thereby limiting the 
amount of Gro/TLE available to form co-repressor complexes with TCF/Lef. In the 
presence of a Wnt signal, XIAP is recruited to TCF/Lef transcriptional complexes 
where it ubiquitylates Gro/TLE.  Ubiquitylation of Gro/TLE decreases its affinity for 
TCF/Lef and allows for the efficient recruitment and binding of the transcriptional 
co-activator β-catenin to TCF/Lef in order to initiate a Wnt-specific transcriptional 
program. 
 
 
 
Figure 6.1.  Model of XIAP-mediated regulation of Groucho/TLE in the 
Wnt pathway.   
See text for details. 
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Our proposed model for Wnt-mediated transcriptional activation parallels 
the findings of Sierra and colleagues who proposed that inactivation of Wnt target 
gene transcription similarly occurs as a multi-step process (Sierra et al., 2006). 
Their data suggest that APC and β-TRCP (an E3 ligase) mediate the removal of 
β-catenin from Lef1 to allow for subsequent TLE1 binding. Together, these 
experiments, and our current study, have revealed that transcriptional activation 
and inactivation in the Wnt pathway are highly regulated processes.  
β-catenin protein levels are tightly regulated in the cell via constant 
synthesis and degradation by the β-catenin destruction complex. Why, then, 
would a cell evolve an additional layer of regulation for Wnt transcriptional 
activation, as we propose here, as opposed to a mechanism driven simply by the 
bimolecular association between β-catenin and TCF/Lef?  We propose that this 
Wnt signaling circuitry provides a mechanism to dampen transcriptional noise 
without a corresponding loss in sensitivity. Binding of Gro/TLE to TCF/Lef allows 
the system to be resistant to stochastic fluxes in β-catenin levels in the absence of 
Wnt pathway activation. In the presence of a Wnt signal, a coincident circuit 
involving nuclear accumulation of β-catenin and recruitment of XIAP to TCF/Lef is 
established. Such circuitry ensures that transcriptional activation only occurs upon 
Wnt ligand binding and provides an additional mechanism for reducing 
spontaneous activity. Sensitivity to a Wnt signal is maintained by the facilitated 
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removal of Gro/TLE from TCF/Lef, which ensures that even low levels of β-catenin 
would be sufficient to bind TCF/Lef and activate transcription.  
Support for this model comes from a study demonstrating that β-catenin 
levels change only modestly (~2-6-fold) upon Wnt signaling in human cells and 
Xenopus embryos (Goentoro and Kirschner, 2009). It is unlikely that the modest 
accumulation of nuclear β-catenin that occurs upon Wnt pathway activation is 
sufficient to effectively displace Gro/TLE from TCF/Lef. This suggests that a 
facilitated mechanism for the removal of Gro/TLE is required prior to formation of 
a β-catenin-TCF/Lef complex.  
In addition to its role in regulating the TCF/Lef transcriptional switch, our 
data indicate that XIAP may also regulate the nuclear pool of Gro/TLE that is 
available to form co-repressor complexes with TCF/Lef. Here, we find that XIAP 
is associated with Gro/TLE in the presence and absence of Wnt signaling. 
Additionally, whereas ubiquitylated Gro/TLE is readily observed in total cellular 
lysates, only the non-ubiquitylated form of Gro/TLE binds to TCF/Lef. This 
suggests a model in which XIAP functions to constitutively ubiquitylate free 
Gro/TLE to control the pool of Gro/TLE that can bind TCF/Lef. Our data also 
suggest the presence of an as yet unidentified de-ubiquitylase (DUB) that 
facilitates the removal of ubiquitin from Gro/TLE, which would allow TCF/Lef 
binding (Figure 6.1). This cycle of mono-ubiquitylation and de-ubiquitylation has 
been shown to regulate the activity of the transcriptional activators Smad4, p53, 
and FoxO (Dupont et al., 2009; Li et al., 2003; van der Horst et al., 2006). Our 
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study provides the first evidence for similar regulation of a transcriptional 
repressor, indicating this may be a general mechanism for transcription factor 
regulation in the cell.  
Until recently, most studies have focused on transcriptional co-activator 
activity because it was generally believed that co-repressors are abundant 
proteins subject to little regulation. It is becoming clear, however, that co-
repressor activity is highly complex and can be controlled through a variety of 
mechanisms (Cinnamon and Paroush, 2008; Perissi et al., 2010). Here, we show 
that the co-repressor Gro/TLE is regulated by ubiquitylation in a manner that may 
be Wnt-pathway specific. Gro/TLE has been shown to participate in 
transcriptional repression of multiple signaling pathways (Buscarlet and Stifani, 
2007). The co-repressor function of Gro/TLE occurs locally through its binding to 
DNA-bound transcription factors (primarily via its C-terminal WD40 domain) and 
histone deacetylase recruitment, and globally via its N-terminal Q domain, which 
mediates oligomerization to alter chromatin structure and mediate long-range 
repression. Our finding that XIAP ubiquitylates Gro/TLE on its N-terminal Q 
domain (which disrupts TCF/Lef binding), but does not disrupt its capacity to 
oligomerize, suggests that XIAP modification of Gro/TLE may specifically affect 
its Wnt repressive function. This possibility is consistent with our observation that 
XIAP knockdown had no observable effect on Notch signaling. In the absence of 
Notch signaling, Gro/TLE normally binds to the Hairless protein to repress Notch 
target gene activation by the transcription factor, Suppressor of Hairless (Barolo 
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et al., 2002; Nagel et al., 2005). Binding to Hairless occurs via the C-terminal 
WD40 domain of Gro/TLE (Jennings et al., 2006). Thus, ubiquitin modifications of 
Gro/TLE on its N-terminal Q domain would not be expected to disrupt its 
interaction with Hairless in the Notch pathway or other pathways in which 
repression by Gro/TLE occurs via the WD40 domain or via Gro/TLE 
oligomerization.  
The identification of XIAP as a novel Wnt pathway component provides a 
link between apoptosis and Wnt signaling and represents a way for the cell to 
coordinate both survival and proliferation. Wnt signaling has been shown to 
inhibit apoptosis and to be required for the expression of XIAP in cancer cells 
(Chen et al., 2001; Gandhirajan et al., 2010; Suzuki et al., 2004; Wang et al., 
2010). Thus, XIAP may be part of a positive feedback loop involving Wnt 
pathway-induced proliferation and inhibition of apoptosis. Surprisingly, the XIAP 
knock-out mouse has no obvious apoptotic or Wnt phenotypes as would be 
expected given its important role in apoptotic inhibition and our findings indicating 
that XIAP is required for Wnt signaling in cultured human cells and in Xenopus 
embryos. Only exon 1 of XIAP was deleted in the knockout mouse (Harlin et al., 
2001). Thus, it is possible that there is read through that permits expression of 
the C-terminus of XIAP, which includes the RING domain. Alternatively, there 
may be other IAP family members or other E3 ligases that can compensate for 
XIAP function when it is knocked out in the mouse. 
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Our findings may have important clinical implications as XIAP is 
upregulated in a majority of human cancers, and inhibitors of XIAP are currently 
in clinical trials (LaCasse et al., 2008). Drug development has been largely 
focused on developing small molecule and peptide Smac mimetics that bind to 
the BIR domains of XIAP to inhibit its anti-apoptotic function. Here, we show that 
the critical role XIAP plays in Wnt signaling depends on its E3 ligase RING 
domain and is distinct from its anti-apoptotic function. Our results predict that 
small molecules targeting the RING domain of XIAP, rather than its BIR domains, 
would represent more selective inhibitors of Wnt signaling. Alternatively, drugs 
targeting both the anti-apoptotic (caspase binding BIR domains) and pro-Wnt (E3 
ligase RING domain) functions of XIAP (e.g. downregulating XIAP by RNA 
interference) may be particularly effective therapeutics against Wnt-driven 
cancers. Moreover, recent findings indicate that inducing apoptosis results in 
“compensatory proliferation” of surrounding surviving cells due to release of 
mitogenic signals (e.g. Wnt) from dying cells (Bergmann and Steller, 2010), 
further indicating that drugs targeting both aspects of XIAP function may be 
particularly effective anti-cancer therapies even in non-Wnt-driven tumors. 
 
Future Directions 
 Like all scientific inquiry, these studies have raised more questions than 
they have answered.  I will outline some of these important unanswered 
questions here.   
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Is XIAP required for Wnt signaling in the absence of Groucho/TLE? 
 To validate that Groucho/TLE is truly the Wnt pathway target of XIAP, it 
will be important to determine if XIAP is required for Wnt signaling in the absence 
of Groucho/TLE.  If Groucho/TLE is not present to repress Wnt signaling, then 
XIAP should not be required for Wnt signal transduction.  This experiment is 
complicated in mammalian cells as there are five Groucho/TLE isoforms.  Thus, 
the simplest approach would be to knockdown Groucho in Drosophila S2 cells, 
as there is only one Groucho in flies, and ask if DIAP1 is still required for Wg 
signaling using the same assay that was used in my original RNAi screen.  This 
is also complicated by the fact that DIAP1 is thought to be required for cell 
survival in S2 cells and, thus, when it is depleted, cells undergo apoptosis.  I 
have found this to be the case to some extent.  Thus, it may be necessary to 
knock down an effector caspase (i.e. DRONC) to prevent the S2 cells from 
undergoing apoptosis when DIAP1 is knocked down in order to answer this 
question.  
 
What are the sites of XIAP-mediated ubiquitylation on Groucho/TLE? 
 I have narrowed the sites of XIAP-mediated ubiquitylation on 
Groucho/TLE to the N-terminal Q domain of Groucho/TLE, which contains eight 
totally conserved lysine residues.  However, it will be important to determine 
which of the eight lysine residues in the Q domain are the XIAP targets.  
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Identifying the ubiquitylation sites on Groucho/TLE will allow the synthesis of 
Groucho/TLE lysine-to-arginine mutants that are unable to be ubiquitylated by 
XIAP.  These mutants could then be used in experiments to determine if the non-
ubiquitylated form of Groucho/TLE is a better repressor than the wild type form of 
Groucho/TLE.  This could be accomplished by overexpressing the ubiquitylation 
mutant and wild type forms of Groucho/TLE in cultured cells and assaying their 
capacity to inhibit TOPflash activity.  I would predict that the ubiquitylation mutant 
form of Groucho/TLE would be able to inhibit TOPflash at a lower concentration 
than the wild type form of Groucho/TLE.  Alternatively, the kinetics of 
Groucho/TLE dissociation from TCF/Lef in response to Wnt stimulation could be 
tested via chromatin immunoprecipitation (ChIP) to determine if the ubiquitylation 
mutant Groucho/TLE cycles off of TCF/Lef slower than the wild type form, or if it 
does not dissociate from TCF/Lef at all.  These experiments may be potentially 
complicated by the presence of wild type Groucho/TLE in the cell, however, as 
the mutant Groucho/TLE will be able to oligomerize with the wild type form, 
perhaps masking any defects in TCF/Lef dissociation.  Thus, the cleanest 
experiment would involve eliminating all wild type forms of Groucho/TLE and 
then asking questions about the behavior of the ubiquitylation mutant form, which 
is a complicated task.   
 Mapping the ubiquitylation sites on Groucho/TLE will be useful for 
functional assays as just described as well as for determining how modification 
on specific residues might affect the structure and binding interfaces of 
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Groucho/TLE.  At present, the structure of Groucho/TLE has not been solved as 
it is a hard protein to purify, but there are groups working on it.  Once the 
structure of the Q domain of Groucho/TLE is known it will be very interesting to 
see where the modified lysine residues reside within that structure.  Based on a 
protein structure predictor program, (http://swissmodel.expasy.org/) it is predicted 
that all eight lysine residues in the Groucho/TLE Q domain reside on the external 
surface of the molecule and would therefore be available for modification by 
XIAP.  More information is required to know which residues are modified and 
how these modifications might specifically affect interactions between 
Groucho/TLE and TCF/Lef, but not affect Groucho/TLE oligomerization.    
 
What are the concentrations of β-catenin and Groucho/TLE in the nucleus? 
 As discussed above, the prevailing model for how TCF/Lef is converted 
from a transcriptional repressor into an activator involves direct displacement of 
Groucho/TLE by accumulating nuclear β-catenin in response to Wnt stimulation 
(Daniels and Weis, 2005).  However, recent evidence suggests there is not 
enough nuclear β-catenin present in response to Wnt stimulation to simply 
outcompete Groucho/TLE for TCF/Lef binding (Goentoro and Kirschner, 2009).  
My data show that Groucho/TLE must be removed from TCF/Lef before β-
catenin can bind, further suggesting that β-catenin cannot directly displace 
Groucho/TLE on its own.  In order to really prove that Groucho/TLE must be 
removed from TCF/Lef in order for β-catenin to bind, however, some rigorous 
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biochemical measurements and mathematical modeling must be performed.  At 
present, the only precise measurement known for these three proteins in the cell 
is the Kd for the β-catenin-TCF/Lef interaction, which was reported to be about 20 
nM (Daniels and Weis, 2005).  Thus, the Kd for the Groucho/TLE-TCF/Lef 
interaction must be determined as well as the nuclear concentrations of Groucho, 
TCF/Lef and β-catenin in the absence and presence of Wnt stimulation.  With 
these measurements, it will be possible to determine if, in fact, enough β-catenin 
enters the nucleus upon Wnt signaling to simply outcompete Groucho/TLE for 
TCF/Lef binding.  This can also be tested theoretically with ordinary differential 
equations (ODEs) for the three proteins using the experimentally verified 
concentrations and Kd’s for each protein to predict the relationship between them 
in the absence and presence of Wnt signaling.  Such precise measurements and 
analysis will give much needed insight into this important nuclear Wnt signaling 
event.   
 
How and when is XIAP recruited to the TCF/Lef transcriptional complex? 
 I have shown that XIAP is recruited to the TCF/Lef transcriptional complex 
upon Wnt stimulation.  The obvious question is:  how?  Some insight comes from 
the fact that XIAP is recruited to TCF/Lef upon LiCl treatment, meaning inhibition 
of GSK3 is sufficient to recruit XIAP to TCF/Lef.  This suggests that this event is 
controlled downstream of β-catenin stabilization in the Wnt pathway.  Perhaps 
XIAP binds β-catenin and is recruited to TCF/Lef along with β-catenin and its 
 128 
binding partners in order to displace Groucho/TLE; this possibility, and others, 
remain to be tested. 
 The more interesting questions are:  what are the kinetics of XIAP-
TCF/Lef association?  When does XIAP come on to TCF/Lef and when does it 
come off?  Is the binding of XIAP to TCF/Lef coordinated with Groucho/TLE 
removal and β-catenin association?  Is XIAP really required for removal of 
Groucho/TLE from TCF/Lef?  What happens when XIAP is knocked down by 
siRNA?  Does Groucho/TLE still cycle off of TCF/Lef in response to Wnt or are 
the kinetics of Groucho/TLE removal slower?  All of these important questions 
can be answered using ChIP assays to look at association and dissociation of 
multiple factors on endogenous Wnt target gene promoters in response to Wnt 
stimulation at different time points.  Such studies have been beautifully 
performed in the laboratory of Katherine Jones (Sierra et al., 2006).  We are now 
working with her laboratory to carry out these experiments to address these 
interesting questions.   
 
Does loss of XIAP inhibit tumor formation? 
 One major outstanding question is:  does inhibition of XIAP affect tumor 
growth or formation?  Many drug companies are currently targeting XIAP to 
inhibit tumor growth in combination with chemotherapeutic agents based on its 
anti-apoptotic function.  It would be very interesting to determine if the patients 
who are receiving an anti-sense XIAP oligonucleotide (which would knockdown 
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the entire protein and thus affect the pro-Wnt RING domain of XIAP) have 
decreased Wnt signaling in their tumors.  Given that pharmaceutical companies 
are involved in all of the current XIAP inhibitor clinical trials, patient samples are 
not readily available.  Thus, the next best option is to turn to the APCMin/+ mouse 
model, which is a well-established system for studying the effects of aberrant 
Wnt signaling on intestinal tumorigenesis (Clarke, 2006), to see if loss of XIAP 
inhibits Wnt signaling and tumor growth in this context.  This would be the most 
definitive way to test if XIAP inhibition may be a useful way to inhibit Wnt-driven 
tumor formation.  If that looks promising, it would be interesting to see how 
effective XIAP inhibition might be in preventing the formation or growth of non-
Wnt-driven tumors as well.   
 
What is the DUB that opposes XIAP-mediated Groucho/TLE ubiquitylation? 
 The last major unanswered question raised by this work is:  what is the 
DUB that opposes Groucho/TLE ubiquitylation by XIAP?  I found that 
Groucho/TLE is constitutively ubiquitylated by XIAP, a modification that inhibits 
Groucho/TLE-TCF/Lef binding.  This suggests the existence of a DUB that would 
function to remove the ubiquitin modification on Groucho/TLE to allow TCF/Lef 
binding.  Considering that there are only approximately 79 human DUBs, a small 
functional screen could be performed in which XIAP, His-ub, Groucho/TLE, and 
one of each of the DUBs could be overexpressed in cultured mammalian cells 
and a His-ub assay performed as described above.  Potential “hits” would be 
 130 
DUBs that decrease the amount of XIAP-ubiquitylated Groucho/TLE.  These hits 
could then be followed up with overexpression/knockdown studies to determine 
effects on Wnt signaling in cultured cells and Xenopus embryos, and, ultimately, 
to determine if they affect the pool of Groucho/TLE available for TCF/Lef binding, 
as would be predicted.     
 
Part II 
 
Discussion 
 Ubiquitylation plays an important role in regulating many Wnt pathway 
components.  Prior to beginning this work, however, no DUBs in the Wnt 
pathway had been identified.  At present, DUBs for TCF (Zhao et al., 2009), Axin 
(Zhang et al., 2011), APC (Tran et al., 2008), and Dsh (Tauriello et al., 2010) 
have now been reported that regulate either the stability or activity of these 
proteins.  In this work, I identified USP47 as a novel DUB involved in the 
regulation of Wnt signaling and show that it associates with two Wnt pathway E3 
ligases, β-TRCP and XIAP.   
 
USP47 and β-TRCP 
 The finding that USP47 interacts with β-TRCP was very interesting given 
that β-TRCP is the primary E3 ligase responsible for regulating cytoplasmic β-
catenin levels in the Wnt pathway.  Given that many DUBs regulate the stability 
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of their cognate E3s, I expected to find that USP47 plays a role in stabilizing β-
TRCP.  However, my data, and that of Peschiaroli and colleagues show this is 
not likely the case (Peschiaroli et al., 2010).  The work of Peschiaroli et al. also 
showed that β-TRCP has no effect on the stability of USP47 even though USP47 
binds the substrate-recognition WD-40 domain of β-TRCP.  Thus, USP47 and β-
TRCP do not likely regulate the stability of each other.   
 Another possibility is that USP47 may affect the levels of the classic Wnt 
pathway β-TRCP substrate, β-catenin.  Although USP47 does not appear to 
interact with β-catenin (data not shown), it is still possible that USP47 can affect 
the ubiquitylation or stability of β-catenin via its interaction with β-TRCP; 
however, my data indicate that USP47 does not affect the stability of β-catenin, 
ruling out this possibility. 
    The last apparent possibility for how USP47 may be affecting Wnt 
signaling via its interaction with β-TRCP is by affecting the ubiquitylation or 
stability of the β-TRCP substrate, Smad4.  A paper published by Wan et al., 
showed that Smad4 is ubiquitylated by β-TRCP and subsequently degraded by 
the proteasome (Wan et al., 2004).  Numerous papers have now shown that 
Smad4 can act as both a positive and negative regulator of Wnt signaling in 
different contexts (Li et al., 2011; Lim and Hoffmann, 2006; Romero et al., 2008; 
Tian et al., 2009).  Thus, I sought to determine if USP47 might be affecting Wnt 
signaling by affecting Smad4 levels.  Even though my data indicate that USP47 
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can interact with Smad4, it does not appear that USP47 has any effect on its 
stability.   
 Ubiquitylation of a protein can have many consequences besides targeting 
it for proteasomal degradation.  Thus, even though USP47 does not observably 
affect the stability of β-TRCP, β-catenin, or Smad4, it is possible that USP47 may 
affect a non-degradative ubiquitin modification on these proteins, which could 
result in changes in their localization, binding partners, or activity.  Most notably, 
mono-ubiquitylation of Smad4 has been shown to be critical in regulating its 
transcriptional activity by regulating its association with its transcriptional co-
activator Smad2 and its nuclear localization (Dupont et al., 2009; Tian et al., 
2009).  Thus, it will be important to test whether USP47 affects non-degradative 
ubiquitin modifications on these proteins in the future, as described below.            
 
USP47 and XIAP 
 In light of my discovery of XIAP as a new Wnt pathway component (see 
Chapter III), it was exciting to find that USP47 also interacts with this E3 ligase.  
My data indicate that USP47 is likely a positive Wnt regulator.  Because XIAP is 
also a positive Wnt regulator, if USP47 affects XIAP function in the Wnt pathway, 
it must be doing so in a positive manner.  This rules out the possibility that 
USP47 could be a DUB for XIAP’s substrate, Groucho/TLE, as removing the 
XIAP-mediated ubiquitin modification on Groucho/TLE would be predicted to 
inhibit, not enhance, Wnt signaling (see Chapter III for details).  This leaves the 
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possibility that USP47 might affect the ubiquitylation or stability of XIAP itself; 
however, my data do not show any observable effects on XIAP levels in either 
the presence or absence of USP47.  There are also no observable changes in 
USP47 levels in the presence or absence of XIAP, ruling out the possibility that 
XIAP and USP47 regulate the stability of one another in the cell.        
 As discussed above, it is possible that USP47 affects a non-degradative, 
inhibitory ubiquitin modification on XIAP that must be removed to allow XIAP to 
ubiquitylate Groucho/TLE to promote Wnt signaling.  This possibility remains to 
be tested as discussed below.   
It is interesting to note the recently reported role for USP47 in regulating 
cell growth and survival, which is similar to the role of XIAP in promoting cell 
survival.  Peschiaroli et al., reported significant decreases in cell growth and 
survival when USP47 was knocked down with siRNA, which was enhanced upon 
treatment with chemotherapeutic agents (Peschiaroli et al., 2010), much like in 
cells that are XIAP deficient (Engesaeter et al., 2011; Wang et al.).  One 
explanation for this comes from the discovery that USP47 is a critical component 
of the DNA base excision repair process in cells by functioning as a DUB for 
polymerase β (Pol β) (Parsons et al., 2011).  Parsons et al., show that USP47 
rescues Pol β from ubiquitin-mediated degradation when it is needed in response 
to DNA damage.  Thus, without USP47 there is not enough Pol β present in the 
cell and the cell becomes more susceptible to DNA damage resulting in 
decreased growth and survival.  Another explanation is possible, however.  
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USP47 may affect XIAP function in the Wnt pathway (a possibility that remains to 
be determined) as well as its function as an inhibitor of apoptosis.  Just as 
USP47 may be required for XIAP to effectively ubiquitylate Groucho/TLE, it may 
also be required for XIAP to effectively inhibit apoptosis.  In support of this 
possibility, the Drosophila homolog of USP47, Ubp64E, has recently been shown 
to genetically interact with dcp-1 (one of the major effector caspases in the fly) 
(Kim et al., 2010), indicating USP47 may regulate apoptotic events in the cell, 
potentially through its interaction with XIAP.  These interesting possibilities 
remain to be tested.    
 
USP47 and Transcription 
My findings indicate that USP47 is required downstream of the β-catenin 
destruction complex in the Wnt pathway as knockdown or overexpression of 
USP47 has no effect on β-catenin levels in the cell.  Thus, even though USP47 
appears to be predominantly a cytoplasmic protein based on my data and 
(Parsons et al., 2011), it is likely playing a role at the level of transcription in the 
nucleus in the Wnt pathway.  This discrepancy in localization and function is not 
novel.  XIAP is predominantly a cytoplasmic protein and β-TRCP’s role in the Wnt 
pathway has largely been attributed to its cytoplasmic role of regulating β-catenin 
levels in the β-catenin destruction complex, but both XIAP and β−TRCP have 
newly discovered critical nuclear Wnt signaling functions.  XIAP is recruited to 
TCF/Lef upon Wnt stimulation in order to ubiquitylate Groucho/TLE to allow β-
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catenin binding (Chapter III), while β-TRCP appears to be required for the 
removal of β-catenin from the TCF/Lef complex to allow for association of 
Groucho/TLE (Sierra et al., 2006).  What recruits XIAP, β-TRCP, and potentially 
USP47 to the nucleus is an important unanswered question.   
That USP47 may be involved in transcriptional events in the Wnt pathway 
is consistent with the reported functions of its homolog, Ubp64E, in Drosophila.  
Ubp64E was originally identified as a strong dominant enhancer of position effect 
variegation (PEV) in Drosophila (Henchoz et al., 1996).  PEV refers to the 
process of a gene becoming inactivated by random insertion next to 
heterochromatin, most often in peri-centrosomal regions (Girton and Johansen, 
2008).  In their study, Henchoz et al. showed that loss of Ubp64E increased the 
spread of heterochromatin in the white gene locus while gain of Ubp64E 
suppressed the spread of heterochromatin, indicating Ubp64E promotes 
chromosome de-condensation.  Ubp64E was the first enzyme discovered to be 
either a suppressor or an enhancer of PEV as almost all other suppressors or 
enhancers identified at that time were transcription factors.  To date, only one 
other DUB, USP22, has been identified as a modulator of PEV and an important 
regulator of chromatin dynamics (Fodor et al., 2010).  USP22 is known to de-
ubiquitylate Histone H2B, which is required for chromosome de-condensation 
(Zhang et al., 2008; Zhao et al., 2008).  It remains to be determined how Ubp64E 
promotes euchromatin formation.  One intriguing possibility is that Ubp64E 
disrupts Groucho/TLE function in coordination with XIAP.   
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In addition to the role of Ubp64E in PEV, it has also been shown to 
regulate the stability of two transcription factors:  Slowborders (a transcriptional 
activator required for border cell migration in fly ovaries), and Tramtrack (a 
transcriptional repressor involved in fly eye development) (Bajpe et al., 2008; 
Rorth et al., 2000).  Thus, even though USP47 is mostly found in the cytoplasm, 
much evidence exists to suggest one of its primary roles in the cell is to regulate 
chromosome dynamics and gene transcription.  This implies that USP47 may be 
involved in regulating one of the many important transcriptional events in the Wnt 
pathway either through XIAP, β-TRCP, their substrates, or an as yet unidentified 
target.    
 
Future Directions 
 The data presented in Chapter V are part of a work in progress.  Thus, 
additional experiments must be performed to confirm and support the results as 
stated.  I will briefly go over the important missing pieces required to interpret the 
current data before focusing on the broader, more interesting future directions of 
this project. 
 
Is USP47 required for Wnt signaling in mammalian cells? 
 To confirm that USP47 is required for Wnt signaling in mammalian cells, it 
will be important to determine if USP47 is required for transcription of 
endogenous Wnt target genes such as AXIN2 or c-myc via RT-PCR analysis of 
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USP47 siRNA-treated samples.  Additionally, determining the requirement for 
USP47 in different cell lines is important to confirm that USP47 is required for 
Wnt signaling in multiple cell types.  To confirm that USP47 is acting downstream 
of the β-catenin destruction complex, it will be necessary to determine if 
knockdown of USP47 via siRNA is able to inhibit LiCl-mediated activation of Wnt 
signaling.  Lastly, to confirm that USP47 enhances Wnt signaling in mammalian 
cells, it will be necessary to repeat the overexpression studies and to immunoblot 
for both the wild type and mutant forms of USP47 to ensure they are being 
expressed in the cellular lysates.   
 
Is USP47 required for Wnt signaling in Xenopus embryos? 
 While the data presented here strongly indicate that USP47 is required for 
Wnt signaling in Xenopus embryos, more rigorous studies must be performed to 
fully support this statement.  First, it must be shown that knockdown of USP47 
via injection of USP47 morpholino inhibits the formation of Xwnt8-induced 
secondary axes, which would show loss of USP47 specifically inhibits Wnt 
signaling.  Second, effects of gain and loss of USP47 function on endogenous 
Xwnt8 target gene expression (i.e. Siamois and Xnr3) in animal caps must be 
determined to show truly specific effects of USP47 on Wnt signaling in Xenopus 
embryos.   
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Does USP47 bind endogenous Smad4 and XIAP? 
 The co-immunoprecipitation experiment (Figure 5.6B) indicating 
overexpressed USP47 and Smad4 interact is weak and needs to be repeated in 
order to determine if USP47 really binds Smad4.  Additionally, it would be best to 
test if endogenous USP47 and Smad4 can interact to determine if they normally 
form a complex in untreated cells.  Given that USP47 and β-TRCP have now 
been reported to interact (Peschiaroli et al., 2010), that data does not need to be 
repeated.  However, it would be good to show that endogenous USP47 interacts 
with endogenous XIAP to confirm the interaction of these two proteins as well.    
 
Does USP47 affect the localization or ubiquitylation of β-TRCP, β-catenin, 
Smad4, XIAP or Groucho/TLE? 
 Given that USP47 does not affect the stability of β-TRCP, β-catenin, 
Smad4, XIAP, or Groucho/TLE the question remains:  does USP47 affect either 
the localization or ubiquitylation of any of these proteins?  Changes in protein 
localization can be assessed by overexpression or siRNA knockdown of USP47 
followed by immunofluorescence microscopy using antibodies against the 
endogenous proteins where available.  If no immunofluorescence amenable 
antibodies exist, tagged versions of proteins can be used instead.  In addition, 
nuclear and cytoplasmic fractionation studies can be employed to determine if 
overexpression or knockdown of USP47 induces changes in the localization of 
each protein.  These studies should also be performed in the presence and 
 139 
absence of Wnt stimulation to determine if Wnt signaling has any effect on the 
subcellular localization of each protein.   
 The next step is to determine if USP47 might affect a non-degradative 
ubiquitin modification on any of the aforementioned proteins.  There are currently 
no reports of non-degradative ubiquitin modifications on β-TRCP, β-catenin, or 
XIAP, however, that does not mean they do not exist.  Smad4 and Groucho/TLE, 
on the other hand, are both critically regulated by non-degradative mono-
ubiquitylation (Dupont et al., 2009)(Chapter IV).  Thus, it will be important to 
determine if gain or loss of USP47 has any effect on the ubiquitylation status of 
each of these proteins by performing in vivo His-ubiquitylation assays when 
USP47 is overexpressed or knocked down via siRNA.  If a change is observed in 
the ubiquitylation status of a protein, it will be important to determine what kind of 
ubiquitin modification it is using ubiquitin mutants and to show that USP47 can 
de-ubiquitylate that substrate both in vivo and in vitro.  
 
Is USP47 involved in Wnt-mediated transcriptional events in the nucleus? 
 As discussed above, much evidence exists to suggest USP47 is an 
important regulator of transcriptional events in the cell and my data indicate that 
USP47 is likely functioning at the level of transcription in the Wnt pathway.  Thus, 
it will be important to probe this interesting possibility.  First, it will be interesting 
to determine if USP47 might be functioning with XIAP as part of the mechanism 
to disrupt Groucho/TLE-TCF/Lef binding.  To this end, it will be necessary to test 
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whether USP47 is recruited to the TCF/Lef complex in response to Wnt signaling 
in the same manner as XIAP.  This can be done by performing co-
immunoprecipitation experiments or chromatin immunopreciptiation (ChIP) 
analyses looking at various time points after Wnt stimulation to see when USP47, 
XIAP, and Groucho/TLE might come on and off TCF/Lef on Wnt target genes 
and whether these events are coordinated.   
Alternatively, perhaps USP47 functions as part of the mechanism to 
remove β-catenin from TCF/Lef via β-TRCP.  This possibility could also be tested 
using ChIP analysis to determine if USP47 might cycle on and off of TCF/Lef in a 
manner similar to β-TRCP or β-catenin, which might give insight into its function 
within the Wnt transcriptional complex.  
Lastly, it might be useful to examine Smad4-TCF/Lef interactions in the 
absence and presence of USP47 to determine if USP47 may affect the ability of 
Smad4 to form a transcriptional complex with TCF/Lef in the Wnt pathway.  This 
can also be accomplished using both co-immunoprecipiation experiments and 
ChIP analysis in cultured cells in which USP47 has been either overexpressed or 
knocked down.  
 
What is the USP47 substrate in the Wnt pathway? 
 After all of the above experiments have been performed, it is still possible 
that the substrate and molecular mechanism of USP47 will not be determined.  If 
that is the case, more screening will be needed.  Two approaches can be utilized 
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in this instance:  1.  Purification of USP47 from cultured mammalian cells 
followed by mass spectrometry analysis to identify novel binding partners, or 2.  
A candidate approach in which USP47 is immunoprecipitated from cultured cells 
in the presence and absence of Wnt stimulation and assayed for interaction with 
all of the known nuclear Wnt components via immunoblotting.  If a novel USP47 
interactor is found via one of these methods, its stability, localization, and 
ubiquitylation status should be tested in the context of USP47 gain and loss of 
funciton to determine the likelihood that it is, in fact, a Wnt-pathway substrate of 
USP47.  
 
Significance 
 Through a siRNA screen performed in Drosophila S2 cells I identified a 
novel E3 ligase and deubiquitylase involved in regulating Wg/Wnt signaling.  
Although the significance of the discovery of Ubp64E/USP47 as a Wg/Wnt 
signaling regulator remains to be determined, the significance of the identification 
of DIAP1/XIAP as a novel Wg/Wnt signaling component is readily apparent given 
the well-established role for XIAP in human cancer.  Overexpression of XIAP has 
been observed in nearly every cancer type analyzed, including all 60 cell lines of 
the National Cancer Institute tumor cell line panel (Fong et al., 2000; Tamm et 
al., 2000).  The most often-cited explanation for why XIAP is routinely 
upregulated in cancer cells focuses on the capacity of XIAP to inhibit apoptosis 
and, thus, prevent cancer cell death.  While this is certainly part of the reason, 
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my studies, and those of others, provide evidence that cancer cells not only 
upregulate XIAP to prevent apoptosis, but also to increase proliferation (via Wnt 
signaling) and to promote metastasis (via NF-κB signaling) (Mehrotra et al., 
2010).   
  In the work presented here, I identify XIAP as a critical Wnt signaling 
component.  This finding provides a novel link between apoptosis and Wnt 
signaling and represents a way for a cell to coordinate both survival and 
proliferation within one protein.  The requirement of XIAP for Wnt signal 
transduction ensures that Wnt-induced proliferation will only occur in non-
apoptotic cells, as XIAP inhibits apoptosis.  In fact, it has been reported that Wnt 
signaling promotes the expression of XIAP (Chen et al., 2001; Gandhirajan et al., 
2010; Suzuki et al., 2004; Wang et al., 2010), thus forming a positive feedback 
loop within a cell involving Wnt pathway-induced proliferation and inhibition of 
apoptosis.  
 This positive feedback loop between Wnt signaling and XIAP may be part 
of the reason why many cancers exhibit hyperactive Wnt signaling (Reya and 
Clevers, 2005).  Mutations that render the Wnt pathway constitutively active 
provide a potential cancer cell with a dual advantage:  growth factor independent 
proliferation and enhanced cell survival, two traits critical for cancer formation 
(Hanahan and Weinberg, 2011).  In colorectal cancer (CRC), the most well 
studied Wnt-driven cancer, it is thought that cancer cells must survive long 
enough to acquire a series of step-wise mutations that occur over a period of 
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decades in order for an invasive tumor to form (Figure 6.2)(Kinzler and 
Vogelstein, 1996).  During this long progression from tumor initiation to invasion, 
there are many circumstances in which a cancer cell is exposed to harsh 
environments that would normally cause cell death.  A successful cancer cell 
must survive loss of cell-cell and cell-matrix attachments, hypoxia,  
overexpression of oncogenes, and massive DNA damage, in order to become a 
fully invasive and malignant tumor (Hanahan and Weinberg, 2011).  Thus, 
constitutive Wnt signaling, and resultant XIAP expression, not only increases the 
proliferative potential of a cell, but it makes it more likely to survive long enough 
to acquire the other mutations needed to form a fully invasive tumor.     
Figure 6.2. Genetic changes associated with colorectal tumorigenesis. 
APC mutations initiate the neoplastic process, and tumor progression results 
from mutations in the other genes indicated. Patients with Familial 
Adenomatous Polyposis inherit APC mutations and develop numerous 
dysplastic aberrant crypt foci (ACF), some of which progress as they acquire 
the other mutations indicated in the figure.   K-RAS is an oncogene that 
requires only one genetic event for its activation. The other specific genes 
indicated are tumor suppressor genes that require two genetic events (one in 
each allele) for their inactivation. Chromosome 18q21 may contain several 
different tumor suppressor genes involved in colorectal neoplasia, with DCC, 
DPC4, and JV18–1 genes proposed as candidates. A variety of other genetic 
alterations have each been described in a small fraction of advanced 
colorectal cancers. These may be responsible for the heterogeneity of biologic 
and clinical properties observed among different cases.  Figure adapted from 
(Kinzler and Vogelstein, 1996). 
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 This dual role of Wnt signaling may partly explain why mutations in the 
Wnt pathway are most often the first “hit” in the progression of CRC (Figure 6.2).  
Why Wnt pathway activation most often occurs before Ras activation is unclear, 
based on this proposed hypothesis, as Ras also induces proliferation and has 
also been shown to upregulate XIAP expression to enhance cell survival (Liu et 
al., 2005b).  Perhaps Wnt mutations are favored early to select for a stem cell-
like cell as Wnt signaling has been shown to be required for maintaining 
“stemness” in the colon and “cancer stem cells” have been postulated as the 
major driving force in tumor initiation and progression (Beachy et al.; Reya and 
Clevers, 2005).  Once a stem cell-like cell is selected, it may then be further 
transformed by an activating Ras mutation that has many oncogenic effects on 
the cell in addition to the myriad Wnt signaling effects.      
 The real question, then, is why do CRC cells, and cancer cells in general, 
so often lose p53 if XIAP is so often expressed at high levels, which presumably 
inhibits apoptosis?  One possibility is that p53 is lost not because of its role as an 
apoptotic effector, but because of its many other tumor suppressor functions 
within cells.  This appears to be the case given that loss of p53 had no effect on 
the frequency of apoptosis in ApcMin/+ mouse early or late stage adenomas, 
leading the authors of this study to conclude that p53 is most likely lost either to 
prevent cellular senescence or to increase the angiogenic potential of cancer 
cells (Fazeli et al., 1997).  Alternatively, or additionally, p53 may be lost to allow 
cell migration.  In CRC, p53 is most often lost just prior to tumor invasion and 
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metastasis (Figure 6.2) suggesting that p53 may be functioning as a metastasis 
suppressor that must be lost in order for tumor invasion to occur.  There is a lot 
of evidence to support this idea.  p53 has been shown to regulate the expression 
of the important metastasis suppressors KIA1, Nm23, and E-cadherin (Marreiros 
et al., 2005; Mashimo et al., 1998; Roger et al., 2010).  Thus, loss of p53 results 
in loss of expression of these genes, which significantly increases the metastatic 
potential of cancer cells.  p53 has also been shown to prevent RhoA activation by 
Ras, suggesting an important function of p53 is to prevent Ras-mediated cell 
migration (Xia and Land, 2007).  Thus, p53 may be lost in CRC, and other 
cancers containing anti-apoptotic activity, not because it increases apoptotic-
resistance, but rather because losing p53 confers other important growth 
advantages to cancer cells.  
 Interestingly, a recent study showed that XIAP also directly promotes 
metastasis independently of its anti-apoptotic function.  XIAP induces NF-κB 
signaling in cooperation with another IAP family member, Survivin, which leads to 
increased fibronectin expression, β1 integrin signaling, and activation of the cell 
motility kinases FAK and Src (Mehrotra et al., 2010).  Thus, XIAP is a triple threat 
in terms of cancer:  it is required for Wnt-induced proliferation, which is 
commonly found in many cancer types, it prevents cancer cell death by inhibiting 
apoptosis, and it directly promotes metastasis.  
 Given the multi-faceted role of XIAP in cancer, targeting XIAP would be 
predicted to be a particularly effective chemotherapeutic strategy.  Indeed, many 
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drug companies are targeting XIAP and clinical trials with XIAP inhibitors are 
currently underway (Hunter et al., 2007; LaCasse et al., 2008).  To date, 
however, much work has focused on inhibiting the anti-apoptotic BIR domains of 
XIAP, while my studies, and those of Mehrotra et al., reveal that the anti-
apoptotic function of XIAP is dispensable for its Wnt pathway function and its 
ability to promote metastasis (Mehrotra et al., 2010).  Thus, targeting the entire 
XIAP protein (e.g. with siRNA constructs) would be predicted to be a more 
effective chemotherapeutic strategy as loss of the entire protein would inhibit all 
of the oncogenic functions of XIAP.  One pharmaceutical company, Aegera 
Therapeutics (Montreal, QC, Canada), has designed a XIAP anti-sense 
oligonucleotide (AEG35156) that has proven effective in multiple cancer types in 
pre-clinical studies including pediatric tumors, acute myeloid leukemia (AML), 
breast, ovarian, prostate, lung, and colon cancer (Holt et al., 2011; LaCasse et 
al., 2006; Shaw et al., 2008; Tamm, 2008).  There are currently multiple ongoing 
clinical trials using AEG35156 as a single agent or in combination with other 
chemotherapy drugs (Tamm, 2008).  The only results published from these 
studies so far are from a phase I/II clinical trial evaluating the effects of 
AEG35156 in patients with relapsed/refractory AML, which indicate that 
AEG35156 is very effective in this patient population in combination with 
idarubicin and cytarabine (Schimmer et al., 2009).  It will be interesting to see 
how effective such XIAP antagonists are in multiple cancer types in the future.    
 In conclusion, the work presented here identifies a novel role for XIAP in 
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Wnt signaling, which provides further insight into why XIAP might be highly 
expressed in cancer cells.  These findings also provide rationale for targeting the 
entire XIAP protein in cancer treatment as the role of XIAP in Wnt signaling and 
metastasis is independent of the anti-apoptotic functions of its BIR domains.         
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